Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders

2012, Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis, J Crohns Colitis, 6, 965, 10.1016/j.crohns.2012.09.003

2012, Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management, J Crohns Colitis, 6, 991, 10.1016/j.crohns.2012.09.002

European Crohn’s and Colitis Organisation, 2013, Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations, J Crohns Colitis, 7, 1, 10.1016/j.crohns.2012.09.005

European Crohn’s and Colitis Organisation [ECCO], 2008, European evidence-based consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis, J Crohns Colitis, 2, 1, 10.1016/j.crohns.2007.11.001

European Crohn’s and Colitis Organisation [ECCO], 2008, European evidence-based consensus on the management of ulcerative colitis: current management, J Crohns Colitis, 2, 24, 10.1016/j.crohns.2007.11.002

European Crohn’s and Colitis Organisation [ECCO], 2008, European evidence-based consensus on the management of ulcerative colitis: special situations, J Crohns Colitis, 2, 63, 10.1016/j.crohns.2007.12.001

European Crohn’s and Colitis Organisation, 2016, The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease, J Crohns Colitis, 10, 239, 10.1093/ecco-jcc/jjv213

ECCO, 2015, European evidence-based consensus: inflammatory bowel disease and malignancies, J Crohns Colitis, 9, 945, 10.1093/ecco-jcc/jjv141

2013, Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines, J Crohns Colitis, 7, 556, 10.1016/j.crohns.2013.02.020

World Organisation of Digestive Endoscopy [OMED] and the European Crohn’s and Colitis Organisation [ECCO], 2009, Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus, Endoscopy, 41, 618, 10.1055/s-0029-1214790

European Crohn’s and Colitis Organisation [ECCO], 2014, Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease, J Crohns Colitis, 8, 443, 10.1016/j.crohns.2013.12.013

European Crohn’s and Colitis Organisation [ECCO], 2015, European evidence-based consensus on surgery for ulcerative colitis, J Crohns Colitis, 9, 4, 10.1016/j.crohns.2014.08.012

European Crohn’s and Colitis Organisation, 2013, European evidence-based consensus for endoscopy in inflammatory bowel disease, J Crohns Colitis, 7, 982, 10.1016/j.crohns.2013.09.016

European Society of Pathology [ESP]; European Crohn’s and Colitis Organisation [ECCO], 2013, European consensus on the histopathology of inflammatory bowel disease, J Crohns Colitis, 7, 827, 10.1016/j.crohns.2013.06.001

European Crohn’s and Colitis Organisation [ECCO], 2015, European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases, J Crohns Colitis, 9, 211, 10.1093/ecco-jcc/jju009

European Crohn’s and Colitis Organization, 2015, The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease, J Crohns Colitis, 9, 107, 10.1093/ecco-jcc/jju006

2012, Management of pediatric ulcerative colitis: joint ECCO and ESPGHAN evidence-based consensus guidelines, J Pediatr Gastroenterol Nutr, 55, 340, 10.1097/MPG.0b013e3182662233

1996, Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European collaborative study on inflammatory bowel disease [EC-IBD], Gut, 39, 690, 10.1136/gut.39.5.690

EpiCom group, 2014, East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort, Gut, 63, 588, 10.1136/gutjnl-2013-304636

ECCO-EpiCom, 2013, The burden of inflammatory bowel disease in Europe, J Crohns Colitis, 7, 322, 10.1016/j.crohns.2013.01.010

IBSEN Group, 2013, Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study, Gut, 62, 368, 10.1136/gutjnl-2012-302311

2007, Impact of inflammatory bowel disease on quality of life: results of the European Federation of Crohn’s and Ulcerative Colitis Associations [EFCCA] patient survey, J Crohns Colitis, 1, 10, 10.1016/j.crohns.2007.06.005

2005, Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal World Congress of Gastroenterology, Can J Gastroenterol, 19, 5A, 10.1155/2005/269076

2006, The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications, Gut, 55, 749, 10.1136/gut.2005.082909

1978, Overlap in the spectrum of non-specific inflammatory bowel disease–‘colitis indeterminate’, J Clin Pathol, 31, 567, 10.1136/jcp.31.6.567

2006, Oral mesalamine and clinical remission are associated with a decrease in the extent of long-standing ulcerative colitis, Inflamm Bowel Dis, 12, 537, 10.1097/01.ibd.0000225345.29603.7d

EpiCom Group, 2014, Initial disease course and treatment in an inflammatory bowel disease inception cohort in Europe: the ECCO-EpiCom cohort, Inflamm Bowel Dis, 20, 36, 10.1097/01.MIB.0000436277.13917.c4

IBSEN Study Group, 2009, Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort [IBSEN Study], Scand J Gastroenterol, 44, 431, 10.1080/00365520802600961

2010, Ulcerative colitis in Northern Portugal and Galicia in Spain, Inflamm Bowel Dis, 16, 1227, 10.1002/ibd.21170

2013, Monogenic diseases associated with intestinal inflammation: implications for the understanding of inflammatory bowel disease, Gut, 62, 1795, 10.1136/gutjnl-2012-303956

2011, Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification, Inflamm Bowel Dis, 17, 1314, 10.1002/ibd.21493

1955, Cortisone in ulcerative colitis; final report on a therapeutic trial, Br Med J, 2, 1041, 10.1136/bmj.2.4947.1041

2007, A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis, Gastroenterology, 132, 763, 10.1053/j.gastro.2006.12.038

1950, Ulcerative colitis—course and prognosis, Lancet, 258, 663

Scientific Committee of the European Crohn’s and Colitis Organisation, 2011, Results from the 2nd scientific workshop of the ECCO. I: Impact of mucosal healing on the course of inflammatory bowel disease, J Crohns Colitis, 5, 477, 10.1016/j.crohns.2011.06.009

Scientific Committee of the European Crohn’s and Colitis Organisation, 2011, Results of the 2nd part scientific workshop of the ECCO. II: Measures and markers of prediction to achieve, detect, and monitor intestinal healing in inflammatory bowel disease, J Crohns Colitis, 5, 484, 10.1016/j.crohns.2011.07.003

2012, Results of the 2nd scientific workshop of the ECCO [IV]: therapeutic strategies to enhance intestinal healing in inflammatory bowel disease, J Crohns Colitis, 6, 492, 10.1016/j.crohns.2011.12.016

2005, Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitis, Gut, 54, 782, 10.1136/gut.2004.056358

1963, The course and prognosis of ulcerative colitis, Gut, 4, 299, 10.1136/gut.4.4.299

AGA Institute Medical Position Panel on Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease, 2010, AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease, Gastroenterology, 138, 738, 10.1053/j.gastro.2009.12.037

2005, Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease, Inflamm Bowel Dis, 11, 314, 10.1097/01.MIB.0000160811.76729.d5

Practice Parameters Committee of the American College of Gastroenterology, 2010, Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee, Am J Gastroenterol, 105, 501, 10.1038/ajg.2009.727

1990, Ulcerative colitis and colorectal cancer. A population-based study, N Engl J Med, 323, 1228, 10.1056/NEJM199011013231802

1991, Colorectal cancer in ulcerative colitis. Influence of anatomical extent and age at onset on colitis-cancer interval, Gut, 32, 167, 10.1136/gut.32.2.167

2014, Systematic review with meta-analysis: the declining risk of colorectal cancer in ulcerative colitis, Aliment Pharmacol Ther, 39, 645, 10.1111/apt.12651

EC-IBD Study Group, 2007, Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study, Digestion, 75, 113, 10.1159/000104731

1987, Histologic and colonoscopic assessment of disease extension in ulcerative colitis, Scand J Gastroenterol, 22, 459, 10.3109/00365528708991491

1988, Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres, Gut, 29, 206, 10.1136/gut.29.2.206

2004, Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis, Gastroenterology, 126, 451, 10.1053/j.gastro.2003.11.010

2007, Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study, Gastroenterology, 133, 1099, 10.1053/j.gastro.2007.08.001

2013, Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study, Clin Gastroenterol Hepatol, 11, 1601, 10.1016/j.cgh.2013.06.023

1996, Changes in extent of ulcerative colitis: a study on the course and prognostic factors, Scand J Gastroenterol, 31, 260, 10.3109/00365529609004876

2000, The natural history of ulcerative proctitis: a multicenter, retrospective study. Gruppo di Studio per le Malattie Infiammatorie Intestinali [GSMII], Am J Gastroenterol, 95, 469, 10.1111/j.1572-0241.2000.t01-1-01770.x

2009, The natural history of pediatric ulcerative colitis: a population-based cohort study, Am J Gastroenterol, 104, 2080, 10.1038/ajg.2009.177

1994, Course of ulcerative colitis: analysis of changes in disease activity over years, Gastroenterology, 107, 3, 10.1016/0016-5085(94)90054-X

European Collaborative Study Group of Inflammatory Bowel Disease [EC-IBD], 2007, Ulcerative colitis: patient characteristics may predict 10-yr disease recurrence in a European-wide population-based cohort, Am J Gastroenterol, 102, 1692, 10.1111/j.1572-0241.2007.01265.x

2007, A meta-analysis of the placebo rates of remission and response in clinical trials of active ulcerative colitis, Gastroenterology, 132, 516, 10.1053/j.gastro.2006.12.037

1989, The ‘natural history’ of ulcerative colitis: an analysis of the placebo response, J Clin Gastroenterol, 11, 33, 10.1097/00004836-198902000-00008

2007, Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark, Inflamm Bowel Dis, 13, 481, 10.1002/ibd.20036

1991, Microscopic activity in ulcerative colitis: what does it mean?, Gut, 32, 174, 10.1136/gut.32.2.174

1982, Serum levels of C-reactive protein in Crohn’s disease and ulcerative colitis, Eur J Clin Invest, 12, 351, 10.1111/j.1365-2362.1982.tb02244.x

2005, Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease, Inflamm Bowel Dis, 11, 707, 10.1097/01.MIB.0000173271.18319.53

2007, Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study, Gastroenterology, 133, 423, 10.1053/j.gastro.2007.05.029

1996, Predicting outcome in severe ulcerative colitis, Gut, 38, 905, 10.1136/gut.38.6.905

2004, Serum procalcitonin differentiates inflammatory bowel disease and self-limited colitis, Inflamm Bowel Dis, 10, 229, 10.1097/00054725-200405000-00008

2005, The role of C-reactive protein as an inflammatory marker in gastrointestinal diseases, Nat Clin Pract Gastroenterol Hepatol, 2, 580, 10.1038/ncpgasthep0359

2003, Role of faecal calprotectin as non-invasive marker of intestinal inflammation, Dig Liver Dis, 35, 642, 10.1016/S1590-8658(03)00381-5

2003, Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation, Am J Gastroenterol, 98, 1309, 10.1111/j.1572-0241.2003.07458.x

2007, Enzymes in feces: useful markers of chronic inflammatory bowel disease, Clin Chim Acta, 381, 63, 10.1016/j.cca.2007.02.025

1992, Faecal elastase reflects disease activity in active ulcerative colitis, Scand J Gastroenterol, 27, 139, 10.3109/00365529209165434

2007, Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome, Gut, 56, 1706, 10.1136/gut.2006.113431

2009, Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse, Inflamm Bowel Dis, 15, 1190, 10.1002/ibd.20933

2007, Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy, Am J Gastroenterol, 102, 803, 10.1111/j.1572-0241.2007.01126.x

2008, Calprotectin helps to distinguish between an acute IBD episode and symptoms related to IBS, Inflamm Bowel Dis, 14, 1432

2009, Ulcerative colitis: correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes, Inflamm Bowel Dis, 15, 1851, 10.1002/ibd.20986

2013, Fecal calprotectin more accurately reflects endoscopic activity of ulcerative colitis than the Lichtiger Index, C-reactive protein, platelets, hemoglobin, and blood leukocytes, Inflamm Bowel Dis, 19, 332, 10.1097/MIB.0b013e3182810066

2010, Remission in trials of ulcerative colitis: what does it mean?, Pract Gastroenterol, 30, 17

1991, Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrheal illnesses, Gastroenterology, 100, 1590, 10.1016/0016-5085(91)90657-7

2004, Serologic markers in inflammatory bowel disease: state of the art, Rev Gastroenterol Disord, 4, 167

1998, Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role, Gut, 42, 788, 10.1136/gut.42.6.788

1998, Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease, Gastroenterology, 115, 822, 10.1016/S0016-5085(98)70252-5

2001, Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease, Am J Gastroenterol, 96, 730, 10.1111/j.1572-0241.2001.03613.x

2002, The value of serologic markers in indeterminate colitis: a prospective follow-up study, Gastroenterology, 122, 1242, 10.1053/gast.2002.32980

2004, High-level serum antibodies to bacterial antigens are associated with antibiotic-induced clinical remission in Crohn’s disease: a pilot study, Dig Dis Sci, 49, 1280, 10.1023/B:DDAS.0000037824.66186.e2

2005, Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn’s disease, Gastroenterology, 128, 2020, 10.1053/j.gastro.2005.03.046

2006, Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn’s disease, Gastroenterology, 131, 366, 10.1053/j.gastro.2006.04.030

2007, Anti-flagellin [CBir1] phenotypic and genetic Crohn’s disease associations, Inflamm Bowel Dis, 13, 524, 10.1002/ibd.20106

International Multiple Sclerosis Genetics Consortium; International IBD Genetics Consortium, 2015, Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations, Nat Genet, 47, 979, 10.1038/ng.3359

International IBD Genetics Consortium [IIBDGC], 2012, Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease, Nature, 491, 119, 10.1038/nature11582

2007, The genetics of inflammatory bowel disease, Gastroenterology, 133, 1327, 10.1053/j.gastro.2007.08.032

International Inflammatory Bowel Disease Genetics Consortium; Australia and New Zealand IBDGC; Belgium IBD Genetics Consortium; Italian Group for IBD Genetic Consortium; NIDDK Inflammatory Bowel Disease Genetics Consortium; United Kingdom IBDGC; Wellcome Trust Case Control Consortium; Quebec IBD Genetics Consortium, 2015, High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis, Nat Genet, 47, 172, 10.1038/ng.3176

2006, A genome-wide association study identifies IL23R as an inflammatory bowel disease gene, Science, 314, 1461, 10.1126/science.1135245

2004, Genetic variation in DLG5 is associated with inflammatory bowel disease, Nat Genet, 36, 476, 10.1038/ng1345

2013, Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease, Pharmacol Res, 76, 1, 10.1016/j.phrs.2013.06.007

NIDDK IBD Genetics Consortium, 2010, Genome-wide association identifies multiple ulcerative colitis susceptibility loci, Nat Genet, 42, 332, 10.1038/ng.549

2010, Genome-wide meta-analysis increases to 71 the number of confirmed Crohn’s disease susceptibility loci, Nat Genet, 42, 1118, 10.1038/ng.717

2011, Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47, Nat Genet, 43, 246, 10.1038/ng.764

2015, Polymorphisms in the toll-like receptor and the IL-23/IL-17 pathways were associated with susceptibility to inflammatory bowel disease in a Danish Cohort, PLoS One, 10, e0145302, 10.1371/journal.pone.0145302

UK IBD Genetics Consortium; NIDDK IBD Genetics Consortium, 2016, A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis, Nat Commun, 7, 12342, 10.1038/ncomms12342

International IBD Genetics Consortium [IIBDGC]; International Genetics of Ankylosing Spondylitis Consortium [IGAS]; International PSC Study Group [IPSCSG]; Genetic Analysis of Psoriasis Consortium [GAPC]; Psoriasis Association Genetics Extension [PAGE], 2016, Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci, Nat Genet, 48, 510, 10.1038/ng.3528

2015, Heritability in inflammatory bowel disease: from the first twin study to genome-wide association studies, Inflamm Bowel Dis, 21, 1428

2004, Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences, Gastroenterology, 126, 1504, 10.1053/j.gastro.2004.01.063

2005, Endoscopy in inflammatory bowel disease: indications, surveillance, and use in clinical practice, Clin Gastroenterol Hepatol, 3, 11, 10.1016/S1542-3565(04)00441-0

1982, Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis, Dig Dis Sci, 27, 533, 10.1007/BF01296733

1983, Clinical appearance at diagnosis of ulcerative colitis and Crohn’s disease in a regional patient group, Scand J Gastroenterol, 18, 987, 10.3109/00365528309182127

1986, Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease, Gut, 27, 92, 10.1136/gut.27.1.92

1988, Symptoms and stool patterns in patients with ulcerative colitis, Gut, 29, 342, 10.1136/gut.29.3.342

1992, Ulcerative colitis and Crohn’s disease health status scales for research and clinical practice, J Clin Gastroenterol, 15, 104, 10.1097/00004836-199209000-00005

1997, Clinical uniformity of inflammatory bowel disease at presentation and during the first year of disease in the north and south of Europe. EC-IBD Study Group, Eur J Gastroenterol Hepatol, 9, 353, 10.1097/00042737-199704000-00007

1998, Initial symptoms, extra-intestinal manifestations and course of pregnancy in chronic inflammatory bowel diseases, Med Klin [Munich], 93, 395

1998, Correlation between endoscopic severity and the clinical activity index in ulcerative colitis, Am J Gastroenterol, 93, 2124, 10.1111/j.1572-0241.1998.00607.x

1999, Ulcerative colitis: a 52 years retrospective study, Rev Gastroenterol Peru, 19, 116

2004, From symptom to diagnosis: clinical distinctions among various forms of intestinal inflammation, Gastroenterology, 126, 1518, 10.1053/j.gastro.2004.02.072

2006, Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease, Cochrane Database Syst Rev, CD000279

1999, AGA technical review on the evaluation and management of chronic diarrhea, Gastroenterology, 116, 1464, 10.1016/S0016-5085(99)70513-5

2005, Perianal problems in patients with ulcerative colitis, Inflamm Bowel Dis, 11, 856, 10.1097/01.MIB.0000174373.75977.b9

2007, Inflammatory bowel disease: clinical aspects and established and evolving therapies, Lancet, 369, 1641, 10.1016/S0140-6736(07)60751-X

Ibsen Study Group, 2006, Change of diagnosis during the first five years after onset of inflammatory bowel disease: results of a prospective follow-up study [the IBSEN Study], Scand J Gastroenterol, 41, 1037, 10.1080/00365520600554527

2005, Extraintestinal manifestations in inflammatory bowel disease, World J Gastroenterol, 11, 7227, 10.3748/wjg.v11.i46.7227

EC-IBD Study Group, 2015, Extraintestinal manifestations in Crohn’s disease and ulcerative colitis: results from a prospective, population-based European inception cohort, Scand J Gastroenterol, 50, 300, 10.3109/00365521.2014.991752

2014, Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients, World J Gastroenterol, 20, 17463, 10.3748/wjg.v20.i46.17463

2014, Extraintestinal manifestations of inflammatory bowel disease and the influence of smoking, Digestion, 90, 122, 10.1159/000363228

2014, Systematic review: The epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease, Aliment Pharmacol Ther, 40, 3, 10.1111/apt.12794

2014, Inflammatory bowel disease: an increased risk factor for neurologic complications, World J Gastroenterol, 20, 1228, 10.3748/wjg.v20.i5.1228

2015, Ulcerative colitis is associated with an increased risk of venous thromboembolism in the postoperative period: the results of a matched cohort analysis, Ann Surg, 261, 1160, 10.1097/SLA.0000000000000788

2007, Inflammation and coagulation in inflammatory bowel disease: The clot thickens, Am J Gastroenterol, 102, 174, 10.1111/j.1572-0241.2006.00943.x

2015, Low incidence of venous thromboembolism in inflammatory bowel diseases: prevalence and predictors from a population-based inception cohort, Scand J Gastroenterol, 50, 306, 10.3109/00365521.2014.985708

EC-IBD Study Group, 2014, Thromboembolism in inflammatory bowel disease: results from a prospective, population-based European inception cohort, Scand J Gastroenterol, 49, 820, 10.3109/00365521.2014.910545

2014, Venous thromboembolism in patients with inflammatory bowel diseases: a case-control study of risk factors, Inflamm Bowel Dis, 20, 631, 10.1097/MIB.0000000000000007

2014, Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology, Gastroenterology, 146, 835, 10.1053/j.gastro.2014.01.042

2013, Meta-analysis: the risk of venous thromboembolism in patients with inflammatory bowel disease, Aliment Pharmacol Ther, 37, 953, 10.1111/apt.12294

2014, Venous thrombosis and prothrombotic factors in inflammatory bowel disease, World J Gastroenterol, 20, 4857, 10.3748/wjg.v20.i17.4857

2006, Review article: genetic susceptibility and application of genetic testing in clinical management of inflammatory bowel disease, Aliment Pharmacol Ther, 24, 2, 10.1111/j.1365-2036.2006.03052.x

2015, Familial risk of inflammatory bowel disease: a population-based cohort study 1977-2011, Am J Gastroenterol, 110, 564, 10.1038/ajg.2015.50

2006, Smoking and inflammatory bowel disease: a meta-analysis, Mayo Clin Proc, 81, 1462, 10.4065/81.11.1462

2012, Review article: Ulcerative colitis, smoking and nicotine therapy, Aliment Pharmacol Ther, 36, 997, 10.1111/apt.12086

2012, A prospective study of cigarette smoking and the risk of inflammatory bowel disease in women, Am J Gastroenterol, 107, 1399, 10.1038/ajg.2012.196

2016, Systematic review with meta-analysis: the effect of tobacco smoking on the natural history of ulcerative colitis, Aliment Pharmacol Ther, 44, 117, 10.1111/apt.13663

2001, Impact of cessation of smoking on the course of ulcerative colitis, Am J Gastroenterol, 96, 2113, 10.1111/j.1572-0241.2001.03944.x

2004, Inflammatory bowel disease and smoking: a review of epidemiology, pathophysiology, and therapeutic implications, Inflamm Bowel Dis, 10, 848, 10.1097/00054725-200411000-00019

1989, Does smoking improve colitis?, Scand J Gastroenterol Suppl, 170, 61

1996, Primary sclerosing cholangitis is associated with nonsmoking: a case-control study, Gastroenterology, 110, 1496, 10.1053/gast.1996.v110.pm8613055

1996, Smoking may prevent pouchitis in patients with restorative proctocolectomy for ulcerative colitis, Gut, 38, 362, 10.1136/gut.38.3.362

2006, Does smoking influence the risk of pouchitis following ileal pouch anal anastomosis for ulcerative colitis?, Scand J Gastroenterol, 41, 929, 10.1080/00365520500527482

2009, Appendicitis, mesenteric lymphadenitis, and subsequent risk of ulcerative colitis: cohort studies in Sweden and Denmark, BMJ, 338, b716, 10.1136/bmj.b716

1994, Appendectomy protects against ulcerative colitis, Gastroenterology, 106, 1251, 10.1016/0016-5085(94)90016-7

2001, Appendectomy and subsequent risk of inflammatory bowel diseases, Surgery, 130, 36, 10.1067/msy.2001.115362

2002, Role of appendicitis and appendectomy in the pathogenesis of ulcerative colitis: a critical review, Inflamm Bowel Dis, 8, 277, 10.1097/00054725-200207000-00007

2002, Effects of appendicectomy on the course of ulcerative colitis, Gut, 51, 803, 10.1136/gut.51.6.803

2002, Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn’s disease, Gut, 51, 808, 10.1136/gut.51.6.808

2004, Epidemiology of appendicectomy in primary sclerosing cholangitis and ulcerative colitis: its influence on the clinical behaviour of these diseases, Gut, 53, 973, 10.1136/gut.2003.036483

2015, The ACCURE-trial: the effect of appendectomy on the clinical course of ulcerative colitis, a randomised international multicenter trial [NTR2883] and the ACCURE-UK trial: a randomised external pilot trial [ISRCTN56523019], BMC Surg, 15, 30, 10.1186/s12893-015-0017-1

2004, Systematic review: is ingestion of paracetamol or non-steroidal anti-inflammatory drugs associated with exacerbations of inflammatory bowel disease?, Aliment Pharmacol Ther, 20, 1035, 10.1111/j.1365-2036.2004.02270.x

2006, Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease, Clin Gastroenterol Hepatol, 4, 196, 10.1016/S1542-3565(05)00980-8

2006, Selective use of selective nonsteroidal anti-inflammatory drugs in inflammatory bowel disease, Clin Gastroenterol Hepatol, 4, 157, 10.1016/j.cgh.2005.11.007

2006, Safety of celecoxib in patients with ulcerative colitis in remission: a randomized, placebo-controlled, pilot study, Clin Gastroenterol Hepatol, 4, 203, 10.1016/j.cgh.2005.12.002

2015, Nonsteroidal anti-inflammatory drugs and exacerbations of inflammatory bowel disease, Scand J Gastroenterol, 50, 255, 10.3109/00365521.2014.966753

2003, An open-label trial of the selective cyclo-oxygenase-2 inhibitor, rofecoxib, in inflammatory bowel disease-associated peripheral arthritis and arthralgia, Aliment Pharmacol Ther, 17, 1371, 10.1046/j.1365-2036.2003.01596.x

IBD Section, British Society of Gastroenterology, 2004, Guidelines for the management of inflammatory bowel disease in adults, Gut, 53, V1, 10.1136/gut.2004.043372

2004, Update on the etiology, pathogenesis and diagnosis of ulcerative colitis, Nat Clin Pract Gastroenterol Hepatol, 1, 26, 10.1038/ncpgasthep0031

2007, Unravelling the pathogenesis of inflammatory bowel disease, Nature, 448, 427, 10.1038/nature06005

2006, A population-based case control study of potential risk factors for IBD, Am J Gastroenterol, 101, 993, 10.1111/j.1572-0241.2006.00381.x

2005, Risk factors for inflammatory bowel disease in the general population, Aliment Pharmacol Ther, 22, 309, 10.1111/j.1365-2036.2005.02564.x

IBSEN Study Group, 2007, Are there any differences in phenotype or disease course between familial and sporadic cases of inflammatory bowel disease? Results of a population-based follow-up study, Am J Gastroenterol, 102, 1955, 10.1111/j.1572-0241.2007.01368.x

2003, Ulcerative colitis: clinical presentation and diagnosis, Inflammatory Bowel Diseases, 169

2007, Predicting a change in diagnosis from ulcerative colitis to Crohn’s disease: a nested, case-control study, Clin Gastroenterol Hepatol, 5, 602, 10.1016/j.cgh.2007.02.015

1988, Clinical and laboratory indicators of extent of ulcerative colitis. Serum C-reactive protein helps the most, J Clin Gastroenterol, 10, 41, 10.1097/00004836-198802000-00010

2007, CRP correlates with clinical score in ulcerative colitis but not in Crohn’s disease, Dig Dis Sci, 52, 2063, 10.1007/s10620-006-9691-2

European Society of Pathology; European Crohn’s and Colitis Foundation, 2014, The histopathological approach to inflammatory bowel disease: a practice guide, Virchows Arch, 464, 511

1998, Early predictors of glucocorticosteroid treatment failure in severe and moderately severe attacks of ulcerative colitis, Eur J Gastroenterol Hepatol, 10, 831, 10.1097/00042737-199810000-00003

2015, Clinical predictors of colectomy in patients with ulcerative colitis: systematic review and meta-analysis of cohort studies, J Crohns Colitis, 9, 156, 10.1093/ecco-jcc/jju016

1992, Search for enteric microbial pathogens in patients with ulcerative colitis, Digestion, 53, 121, 10.1159/000200985

1992, Microbic superinfection in relapse of inflammatory bowel disease, J Clin Gastroenterol, 14, 302, 10.1097/00004836-199206000-00008

1983, Occurrence of Clostridium difficile toxin in inflammatory bowel disease, Scand J Gastroenterol, 18, 61, 10.3109/00365528309181560

2008, A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients, Am J Gastroenterol, 103, 1443, 10.1111/j.1572-0241.2007.01780.x

2014, Prevalence and risk factors of Clostridium difficile infection in patients hospitalized for flare of inflammatory bowel disease: a retrospective assessment, Dig Liver Dis, 46, 1086, 10.1016/j.dld.2014.09.003

2014, Diagnosis and management of common gastrointestinal tract infectious diseases in ulcerative colitis and Crohn’s disease patients, Inflamm Bowel Dis, 20, 2503, 10.1097/MIB.0000000000000140

2007, Impact of Clostridium difficile on inflammatory bowel disease, Clin Gastroenterol Hepatol, 5, 345, 10.1016/j.cgh.2006.12.028

2007, Incidence of Clostridium difficile infection in inflammatory bowel disease, Clin Gastroenterol Hepatol, 5, 339, 10.1016/j.cgh.2006.12.027

2013, Is clostridium difficile associated with relapse of inflammatory bowel disease? results from a retrospective and prospective cohort study in the Netherlands, Inflamm Bowel Dis, 19, 2125, 10.1097/MIB.0b013e318297d222

2012, Impact of Clostridium difficile colitis on 5-year health outcomes in patients with ulcerative colitis, Aliment Pharmacol Ther, 36, 1032, 10.1111/apt.12073

2004, Clostridium difficile associated diarrhoea in hospitalised patients: onset in the community and hospital and role of flexible sigmoidoscopy, Gut, 53, 673, 10.1136/gut.2003.028803

2007, Cytomegalovirus infection in severe ulcerative colitis patients undergoing continuous intravenous cyclosporine treatment in Japan, World J Gastroenterol, 13, 754, 10.3748/wjg.v13.i5.754

2007, Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients, Am J Gastroenterol, 102, 331, 10.1111/j.1572-0241.2006.00989.x

2006, Frequent detection of cytomegalovirus in the intestine of patients with inflammatory bowel disease, Inflamm Bowel Dis, 12, 879, 10.1097/01.mib.0000231576.11678.57

2004, The pathogenicity of cytomegalovirus in inflammatory bowel disease: a systematic review and evidence-based recommendations for future research, Inflamm Bowel Dis, 10, 245, 10.1097/00054725-200405000-00011

2006, Cytomegalovirus infection in ulcerative colitis, Scand J Gastroenterol, 41, 706, 10.1080/00365520500408584

2015, Diagnosing cytomegalovirus in patients with inflammatory bowel disease–by immunohistochemistry or polymerase chain reaction?, Virchows Arch, 466, 533, 10.1007/s00428-015-1741-8

2015, Antiviral Therapy in Steroid-refractory Ulcerative Colitis with Cytomegalovirus: Systematic Review and Meta-analysis, Inflamm Bowel Dis, 21, 2718, 10.1097/MIB.0000000000000489

European Collaborative Study Group on Inflammatory Bowel Disease, 2007, The prevalence of genetic and serologic markers in an unselected European population-based cohort of IBD patients, Inflamm Bowel Dis, 13, 24, 10.1002/ibd.20047

2004, Interassay and interobserver variability in the detection of anti-neutrophil cytoplasmic antibodies in patients with ulcerative colitis, Clin Chem, 50, 1422, 10.1373/clinchem.2004.032318

2004, Do serological markers and cytokines determine the indeterminate?, J Clin Gastroenterol, 38, S51, 10.1097/01.mcg.0000124026.92823.fc

2006, Laboratory markers in IBD: useful, magic, or unnecessary toys?, Gut, 55, 426, 10.1136/gut.2005.069476

2002, Review article: faecal markers in the assessment of activity in inflammatory bowel disease, Aliment Pharmacol Ther, 16, 675, 10.1046/j.1365-2036.2002.01196.x

2005, Comparison of 4 neutrophil-derived proteins in feces as indicators of disease activity in ulcerative colitis, Inflamm Bowel Dis, 11, 1085, 10.1097/01.MIB.0000187980.08686.18

2006, Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease, Inflamm Bowel Dis, 12, 524, 10.1097/00054725-200606000-00013

2012, Ruling out IBD: estimation of the possible economic effects of pre-endoscopic screening with F-calprotectin, Clin Biochem, 45, 552, 10.1016/j.clinbiochem.2011.10.015

2015, Evaluation of mucosal healing in ulcerative colitis by fecal calprotectin vs. fecal immunochemical test, Am J Gastroenterol, 110, 873, 10.1038/ajg.2015.66

2014, Meta-analysis: fecal calprotectin for assessment of inflammatory bowel disease activity, Inflamm Bowel Dis, 20, 1407, 10.1097/MIB.0000000000000057

2016, Fecal calprotectin measured by patients at home using smartphones–a new clinical tool in monitoring patients with inflammatory bowel disease, Inflamm Bowel Dis, 22, 336, 10.1097/MIB.0000000000000619

1993, Atypical rectosigmoid histology in children with newly diagnosed ulcerative colitis, Am J Gastroenterol, 88, 2034

2004, Endoscopic rectal sparing in children with untreated ulcerative colitis, J Pediatr Gastroenterol Nutr, 38, 66, 10.1097/00005176-200401000-00015

2004, Patterns of colonic involvement at initial presentation in ulcerative colitis: a retrospective study of 46 newly diagnosed cases, Am J Clin Pathol, 122, 94, 10.1309/XLXKJ84C3JCW3RCH

1999, Endoscopic and histological patchiness in treated ulcerative colitis, Am J Gastroenterol, 94, 3258, 10.1111/j.1572-0241.1999.01533.x

1993, Effect of topical 5-aminosalicylic acid [5-ASA] therapy on rectal mucosal biopsy morphology in chronic ulcerative colitis, Am J Surg Pathol, 17, 869, 10.1097/00000478-199309000-00002

2014, Appendiceal skip inflammation and ulcerative colitis, Dig Dis Sci, 59, 2050, 10.1007/s10620-014-3129-z

2005, Clinical course of distal ulcerative colitis in relation to appendiceal orifice inflammation status, Inflamm Bowel Dis, 11, 366, 10.1097/01.MIB.0000164018.06538.6e

2005, Skip inflammation of the appendiceal orifice: a prospective endoscopic study, Scand J Gastroenterol, 40, 1192, 10.1080/00365520510023305

1999, Appendiceal orifice inflammation as a skip lesion in ulcerative colitis: an analysis in relation to medical therapy and disease extent, Gastrointest Endosc, 49, 743, 10.1016/S0016-5107(99)70293-2

2002, Significance of appendiceal involvement in patients with ulcerative colitis, Gastrointest Endosc, 55, 180, 10.1067/mge.2002.121335

2014, Atypical distribution of inflammation in newly diagnosed ulcerative colitis is not rare, Can J Gastroenterol Hepatol, 28, 125, 10.1155/2014/834512

2005, Pathologic features and clinical significance of ‘backwash’ ileitis in ulcerative colitis, Am J Surg Pathol, 29, 1472

2005, Ileitis in ulcerative colitis: is it a backwash?, Dis Colon Rectum, 48, 2038, 10.1007/s10350-005-0160-3

2006, Contemporary morphologic definition of backwash ileitis in ulcerative colitis and features that distinguish it from Crohn disease, Am J Clin Pathol, 126, 365, 10.1309/UAXMW3428PGN9HJ3

2013, Backwash ileitis and the risk of colon neoplasia in ulcerative colitis patients undergoing restorative proctocolectomy, Dig Dis Sci, 58, 2019, 10.1007/s10620-013-2571-7

2011, Backwash ileitis does not affect pouch outcome in patients with ulcerative colitis with restorative proctocolectomy, Clin Gastroenterol Hepatol, 9, 981, 10.1016/j.cgh.2011.07.018

ECCO, 2017, 3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: part 1: diagnosis and medical management, J Crohns Colitis, 11, 3, 10.1093/ecco-jcc/jjw168

1980, Depth of ulceration in acute colitis: correlation with outcome and clinical and radiologic features, Gastroenterology, 79, 19, 10.1016/0016-5085(80)90069-4

2005, Management of acute severe colitis, Br Med Bull, 75-76, 131, 10.1093/bmb/ldl001

1975, Assessment of severity in colitis: a preliminary study, Gut, 16, 579, 10.1136/gut.16.8.579

1991, Small bowel gas in severe ulcerative colitis, Gut, 32, 1535, 10.1136/gut.32.12.1535

2004, Severe acute colitis associated with CMV: a prevalence study, Dig Liver Dis, 36, 818, 10.1016/j.dld.2004.05.013

1981, Flexible sigmoidoscopy in outpatients with suspected colonic disease, Br Med J, 283, 1291, 10.1136/bmj.283.6302.1291

2012, Severe disease on endoscopy and steroid use increase the risk for bowel perforation during colonoscopy in inflammatory bowel disease patients, J Crohns Colitis, 6, 470, 10.1016/j.crohns.2011.10.005

1994, Colonoscopy of acute colitis. A safe and reliable tool for assessment of severity, Dig Dis Sci, 39, 1550

1998, Observer agreement in endoscopic assessment of ulcerative colitis, Ital J Gastroenterol Hepatol, 30, 539

IBSEN Group, 2007, Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort, Gastroenterology, 133, 412, 10.1053/j.gastro.2007.05.051

1966, Serial rectal biopsy in ulcerative colitis during the course of a controlled therapeutic trial of various diets, Am J Dig Dis, 11, 847, 10.1007/BF02233941

2011, Mucosal healing predicts late outcomes after the first course of corticosteroids for newly diagnosed ulcerative colitis, Clin Gastroenterol Hepatol, 9, 483, 10.1016/j.cgh.2010.12.028

2012, 18, 1006

2012, Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity [UCEIS], Gut, 61, 535, 10.1136/gutjnl-2011-300486

2011, Measurement of disease activity in ulcerative colitis: interobserver agreement and predictors of severity, Inflamm Bowel Dis, 17, 1257, 10.1002/ibd.21480

2013, 987

1987, Colonoscopy in inflammatory bowel disease. Diagnostic accuracy and proposal of an endoscopic score, Gastroenterology, 92, 181, 10.1016/0016-5085(87)90856-0

1964, Variation between observers in describing mucosal appearances in proctocolitis, Br Med J, 1, 89, 10.1136/bmj.1.5375.89

1967, Local complications of ulcerative colitis. Stricture, pseudopolyps and cancer of the colon and rectum, Am J Proctol, 18, 198

2012, Mucosal healing in inflammatory bowel diseases: a systematic review, Gut, 61, 1619, 10.1136/gutjnl-2012-302830

2012, The use of Pillcam Colon in assessing mucosal inflammation in ulcerative colitis: a multicenter study, Endoscopy, 44, 754, 10.1055/s-0032-1309819

1987, Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study, N Engl J Med, 317, 1625, 10.1056/NEJM198712243172603

2005, Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin, N Engl J Med, 352, 2499, 10.1056/NEJMoa042982

2003, Role of early ultrasound in detecting inflammatory intestinal disorders and identifying their anatomical location within the bowel, Aliment Pharmacol Ther, 18, 1009, 10.1046/j.1365-2036.2003.01796.x

1998, The accuracy of abdominal ultrasound in the assessment of bowel disorders, Scand J Gastroenterol, 33, 1201, 10.1080/00365529850172575

1999, Ultrasonography in the evaluation of extension, activity, and follow-up of ulcerative colitis, Scand J Gastroenterol, 34, 1103, 10.1080/003655299750024904

2010, Are colonoscopy and bowel ultrasound useful for assessing response to short-term therapy and predicting disease outcome of moderate-to-severe forms of ulcerative colitis?: a prospective study, Am J Gastroenterol, 105, 1150, 10.1038/ajg.2009.672

2004, Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk, Gut, 53, 1813, 10.1136/gut.2003.038505

2006, Multi-detector CT-colonography in inflammatory bowel disease: prospective analysis of CT-findings to high-resolution video colonoscopy, Eur J Radiol, 58, 140, 10.1016/j.ejrad.2005.11.004

British Society of Gastroenterology, 2013, Inflammatory bowel disease biopsies: updated British Society of Gastroenterology reporting guidelines, J Clin Pathol, 66, 1005, 10.1136/jclinpath-2013-201885

1998, Ulcerative colitis: patterns of involvement in colorectal biopsies and changes with time, Am J Surg Pathol, 22, 983, 10.1097/00000478-199808000-00008

2002, Discriminant histological features in the diagnosis of chronic idiopathic inflammatory bowel disease: analysis of a large dataset by a novel data visualisation technique, J Clin Pathol, 55, 51, 10.1136/jcp.55.1.51

1994, A prospective study of first attacks of inflammatory bowel disease and infectious colitis. Histologic course during the 1st year after presentation, Scand J Gastroenterol, 29, 318, 10.3109/00365529409094843

1991, Histopathological evaluation of colonic mucosal biopsy specimens in chronic inflammatory bowel disease: diagnostic implications, Gut, 32, 1514, 10.1136/gut.32.12.1514

1994, Mucosal biopsy diagnosis of colitis: acute self-limited colitis and idiopathic inflammatory bowel disease, Gastroenterology, 107, 755, 10.1016/0016-5085(94)90124-4

1987, Histopathology differentiates acute self-limited colitis from ulcerative colitis, Gastroenterology, 92, 318, 10.1016/0016-5085(87)90124-7

1990, Mucin depletion in inflammatory bowel disease, J Clin Pathol, 43, 143, 10.1136/jcp.43.2.143

2002, How could pathologists improve the initial diagnosis of colitis? Evidence from an international workshop, J Clin Pathol, 55, 955, 10.1136/jcp.55.12.955

1999, Change in the extent of colonoscopic and histological involvement in ulcerative colitis over time, Am J Gastroenterol, 94, 1564, 10.1111/j.1572-0241.1999.01145.x

2014, Systematic review: histological remission in inflammatory bowel disease. Is ‘complete’ remission the new treatment paradigm? An IOIBD initiative, J Crohns Colitis, 8, 1582, 10.1016/j.crohns.2014.08.011

2000, A reproducible grading scale for histological assessment of inflammation in ulcerative colitis, Gut, 47, 404, 10.1136/gut.47.3.404

2014, Histologic evaluation of ulcerative colitis: a systematic review of disease activity indices, Inflamm Bowel Dis, 20, 564, 10.1097/01.MIB.0000437986.00190.71

2015, Comparing histological activity indexes in UC, Gut, 64, 1412, 10.1136/gutjnl-2014-307477

2017, Development and validation of a histological index for UC, Gut, 66, 50, 10.1136/gutjnl-2015-310393

2001, Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis, Gastroenterology, 120, 13, 10.1053/gast.2001.20912

2006, Pit patterns in rectal mucosa assessed by magnifying colonoscope are predictive of relapse in patients with quiescent ulcerative colitis, Gut, 55, 1768, 10.1136/gut.2005.086900

2006, Predictors of relapse in patients with quiescent ulcerative colitis, Gut, 55, 1760

2012, Prognostic value of serologic and histologic markers on clinical relapse in ulcerative colitis patients with mucosal healing, Am J Gastroenterol, 107, 1684, 10.1038/ajg.2012.301

2013, Clinical implications of histologic abnormalities in colonic biopsy specimens from patients with ulcerative colitis in clinical remission, Inflamm Bowel Dis, 19, 1477, 10.1097/MIB.0b013e318281f4ae

2016, Histology grade is independently associated with relapse risk in patients with ulcerative colitis in clinical remission: a prospective study, Am J Gastroenterol, 111, 685, 10.1038/ajg.2016.50

2014, Histological healing favors lower risk of colon carcinoma in extensive ulcerative colitis, World J Gastroenterol, 20, 4980, 10.3748/wjg.v20.i17.4980

2013, Histologic markers of inflammation in patients with ulcerative colitis in clinical remission, Clin Gastroenterol Hepatol, 11, 991, 10.1016/j.cgh.2013.02.030

2013, Correlation between the endoscopic and histologic score in assessing the activity of ulcerative colitis, Inflamm Bowel Dis, 19, 1194, 10.1097/MIB.0b013e318280e75f

2015, Histological inflammation in ulcerative colitis in deep remission under treatment with infliximab, Clin Res Hepatol Gastroenterol, 39, 107, 10.1016/j.clinre.2014.07.012

2013, Definition and evaluation of mucosal healing in clinical practice, Dig Liver Dis, 45, 969, 10.1016/j.dld.2013.06.010

2014, Histologic remission: the ultimate therapeutic goal in ulcerative colitis?, Clin Gastroenterol Hepatol, 12, 929, 10.1016/j.cgh.2013.07.022

2000, Focal gastric inflammatory infiltrates in inflammatory bowel diseases: prevalence, immunohistochemical characteristics, and diagnostic role, Am J Gastroenterol, 95, 705, 10.1111/j.1572-0241.2000.01851.x

2002, Focally enhanced gastritis in children with Crohn’s disease and ulcerative colitis, Am J Gastroenterol, 97, 1415, 10.1111/j.1572-0241.2002.05785.x

2013, The clinical significance of focally enhanced gastritis in children, Am J Surg Pathol, 37, 295, 10.1097/PAS.0b013e31826b2a94

2013, The value of focally enhanced gastritis in the diagnosis of pediatric inflammatory bowel diseases, J Crohns Colitis, 7, 797, 10.1016/j.crohns.2012.11.003

2013, Focally enhanced gastritis in newly diagnosed pediatric inflammatory bowel disease, Am J Surg Pathol, 37, 1882, 10.1097/PAS.0b013e31829f03ee

2003, Diagnosing colitis: a prospective study on essential parameters for reaching a diagnosis, Endoscopy, 35, 1004, 10.1055/s-2003-44593

2014, Prevalence of anemia in inflammatory bowel diseases in European countries: a systematic review and individual patient data meta-analysis, Inflamm Bowel Dis, 20, 936, 10.1097/01.MIB.0000442728.74340.fd

2013, High burden of iron deficiency and different types of anemia in inflammatory bowel disease outpatients in Scandinavia: a longitudinal 2-year follow-up study, Scand J Gastroenterol, 48, 1286, 10.3109/00365521.2013.838605

2012, High prevalence but insufficient treatment of iron-deficiency anemia in patients with inflammatory bowel disease: results of a population-based cohort, Gastroenterol Res Pract, 2012, 595970

2009, Anemia and inflammatory bowel diseases, World J Gastroenterol, 15, 4659, 10.3748/wjg.15.4659

2007, Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases, Inflamm Bowel Dis, 13, 1545, 10.1002/ibd.20285

2003, Soluble transferrin receptor for the evaluation of erythropoiesis and iron status, Clin Chim Acta, 329, 9, 10.1016/S0009-8981(03)00005-6

2007, Evolution of adverse changes in stored RBCs, Proc Natl Acad Sci U S A, 104, 17063, 10.1073/pnas.0708160104

2005, Anemia of chronic disease, N Engl J Med, 352, 1011, 10.1056/NEJMra041809

Swiss IBD Cohort Study, 2010, Prevalence of anaemia in inflammatory bowel disease in Switzerland: a cross-sectional study in patients from private practices and university hospitals, J Crohns Colitis, 4, 642, 10.1016/j.crohns.2010.07.008

FERGI Study Group, 2011, FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease, Gastroenterology, 141, 846, 10.1053/j.gastro.2011.06.005

2009, Rapid recurrence of IBD-associated anemia and iron deficiency after intravenous iron sucrose and erythropoietin treatment, Am J Gastroenterol, 104, 1460, 10.1038/ajg.2009.114

FERGI Study Group, 2013, Ferric carboxymaltose prevents recurrence of anemia in patients with inflammatory bowel disease, Clin Gastroenterol Hepatol, 11, 269, 10.1016/j.cgh.2012.10.013

1999, Sequential treatment of anemia in ulcerative colitis with intravenous iron and erythropoietin, Digestion, 60, 262, 10.1159/000007667

1997, Intravenous iron and erythropoietin for anemia associated with Crohn disease. A randomized, controlled trial, Ann Intern Med, 126, 782, 10.7326/0003-4819-126-10-199705150-00006

2006, Effectiveness of darbepoetin-alfa in combination with intravenous iron sucrose in patients with inflammatory bowel disease and refractory anaemia: a pilot study, Eur J Gastroenterol Hepatol, 18, 421, 10.1097/00042737-200604000-00017

1999, A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group, N Engl J Med, 340, 409, 10.1056/NEJM199902113400601

2013, Transfusion strategies for acute upper gastrointestinal bleeding, N Engl J Med, 368, 11, 10.1056/NEJMoa1211801

2011, Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort, Am J Gastroenterol, 106, 110, 10.1038/ajg.2010.343

1998, Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history, Gut, 42, 387, 10.1136/gut.42.3.387

2000, Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association, J Rheumatol, 27, 2860

2008, Clinical and genetic factors associated with sacroiliitis in Crohn’s disease, J Gastroenterol Hepatol, 23, 132, 10.1111/j.1440-1746.2007.05108.x

2000, Subclinical sacroiliitis in inflammatory bowel disease: a clinical and follow-up study, Clin Rheumatol, 19, 445, 10.1007/s100670070003

1984, Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria, Arthritis Rheum, 27, 361, 10.1002/art.1780270401

2004, Analysing chronic spinal changes in ankylosing spondylitis: a systematic comparison of conventional x rays with magnetic resonance imaging using established and new scoring systems, Ann Rheum Dis, 63, 1046, 10.1136/ard.2003.019968

2004, MRI abnormalities of sacroiliac joints in early spondylarthropathy: a 1-year follow-up study, Scand J Rheumatol, 33, 332, 10.1080/03009740410005881

2002, Improvement of arthritis and arthralgia after treatment with infliximab [Remicade] in a German prospective, open-label, multicenter trial in refractory Crohn’s disease, Am J Gastroenterol, 97, 2688, 10.1111/j.1572-0241.2002.06064.x

2000, Crohn’s disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptoms, Lancet, 356, 1821, 10.1016/S0140-6736(00)03239-6

2004, Infliximab in spondyloarthropathy associated with Crohn’s disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations, Ann Rheum Dis, 63, 1664, 10.1136/ard.2003.012450

2003, Efficacy of etanercept for treatment of Crohn’s related spondyloarthritis but not colitis, Ann Rheum Dis, 62, 74, 10.1136/ard.62.1.74

2006, Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis, Ann Rheum Dis, 65, 423, 10.1136/ard.2005.041129

2002, Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha [infliximab] versus placebo in active spondylarthropathy, Arthritis Rheum, 46, 755, 10.1002/art.511

2008, Persistent clinical efficacy and safety of anti-tumour necrosis factor alpha therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response, Ann Rheum Dis, 67, 340

2002, Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial, Lancet, 359, 1187, 10.1016/S0140-6736(02)08215-6

2002, Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha, N Engl J Med, 346, 1349, 10.1056/NEJMoa012664

2007, Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis: a multicenter, randomized, double-blind, placebo-controlled study, Arthritis Rheum, 56, 4005, 10.1002/art.23044

Ankylosing Spondylitis Study for the Evaluation of Recombinant Infliximab Therapy Study Group, 2005, Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial [ASSERT], Arthritis Rheum, 52, 582, 10.1002/art.20852

ATLAS Study Group, 2006, Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial, Arthritis Rheum, 54, 2136, 10.1002/art.21913

2006, The gastrointestinal safety and effect on disease activity of etoricoxib, a selective cox-2 inhibitor in inflammatory bowel diseases, Am J Gastroenterol, 101, 311, 10.1111/j.1572-0241.2006.00384.x

2014, Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease, Autoimmun Rev, 13, 822, 10.1016/j.autrev.2014.04.003

2016, American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis, Arthritis Rheumatol, 68, 282, 10.1002/art.39298

2014, Cutaneous manifestations in patients with inflammatory bowel diseases: pathophysiology, clinical features, and therapy, Inflamm Bowel Dis, 20, 213, 10.1097/01.MIB.0000436959.62286.f9

2006, Treatment of chronic erythema nodosum with infliximab, Clin Exp Dermatol, 31, 823, 10.1111/j.1365-2230.2006.02221.x

2007, Refractory chronic erythema nodosum successfully treated with adalimumab, J Eur Acad Dermatol Venereol, 21, 408, 10.1111/j.1468-3083.2006.01893.x

2007, Pyoderma gangrenosum: an update, Rheum Dis Clin North Am, 33, 787, 10.1016/j.rdc.2007.07.016

1985, Clinical course and evolution of erythema nodosum and pyoderma gangrenosum in chronic ulcerative colitis: a study of 42 patients, Am J Gastroenterol, 80, 615

2006, Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial, Gut, 55, 505, 10.1136/gut.2005.074815

2007, Extraintestinal manifestations of Crohn’s disease, Digestion, 76, 141, 10.1159/000111029

2006, Diagnosis and treatment of pyoderma gangrenosum, BMJ, 333, 181, 10.1136/bmj.333.7560.181

1992, Treatment of pyoderma gangrenosum with cyclosporine, Arch Dermatol, 128, 1060, 10.1001/archderm.1992.01680180054005

2003, Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease, Aliment Pharmacol Ther, 17, 1273, 10.1046/j.1365-2036.2003.01534.x

2007, Sweet’s syndrome–a comprehensive review of an acute febrile neutrophilic dermatosis, Orphanet J Rare Dis, 2, 34, 10.1186/1750-1172-2-34

1997, Sweet’s syndrome: an unusual cutaneous feature of Crohn’s disease or ulcerative colitis. The South West Gastroenterology Group, Eur J Gastroenterol Hepatol, 9, 715, 10.1097/00042737-199707000-00013

2005, Sweet’s syndrome–an extraintestinal manifestation in inflammatory bowel disease, Digestion, 72, 195, 10.1159/000088466

2009, Neutrophilic dermatoses: a review of current treatment options, Am J Clin Dermatol, 10, 301, 10.2165/11310730-000000000-00000

2016, Characteristics of skin lesions associated with anti-tumor necrosis factor therapy in patients with inflammatory bowel disease: a cohort study, Ann Intern Med, 164, 10, 10.7326/M15-0729

2014, Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment, Gut, 63, 567, 10.1136/gutjnl-2012-302853

Groupe d’Etude Thérapeutique des Affections Inflammatoires du Tube Digestif [GETAID], 2010, Severe skin lesions cause patients with inflammatory bowel disease to discontinue anti-tumor necrosis factor therapy, Clin Gastroenterol Hepatol, 8, 1048, 10.1016/j.cgh.2010.07.022

2009, Review article: anti TNF-alpha induced psoriasis in patients with inflammatory bowel disease, Aliment Pharmacol Ther, 29, 921, 10.1111/j.1365-2036.2009.03955.x

2015, Cumulative incidence of, risk factors for, and outcome of dermatological complications of anti-TNF therapy in inflammatory bowel disease: a 14-year experience, Am J Gastroenterol, 110, 1186, 10.1038/ajg.2015.205

2015, Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study, Aliment Pharmacol Ther, 42, 880, 10.1111/apt.13352

2012, Induction of psoriasis with anti-TNF agents in patients with inflammatory bowel disease: a report of 21 cases, J Crohns Colitis, 6, 518, 10.1016/j.crohns.2011.10.007

2015, Concomitant use of azathioprine/6-mercaptopurine decreases the risk of anti-TNF-induced skin lesions, Inflamm Bowel Dis, 21, 832, 10.1097/MIB.0000000000000342

2004, Ocular manifestations of inflammatory bowel disease, Inflamm Bowel Dis, 10, 135, 10.1097/00054725-200403000-00012

2016, Prevalence of sclerosing cholangitis detected by magnetic resonance cholangiography in patients with long-term inflammatory bowel disease, Gastroenterology, 151, 660, 10.1053/j.gastro.2016.06.021

2006, The medical management of primary sclerosing cholangitis, Semin Liver Dis, 26, 52, 10.1055/s-2006-933563

1997, Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group, N Engl J Med, 336, 691

2003, Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis, Gastroenterology, 124, 889, 10.1053/gast.2003.50156

2004, Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and/or DNA-aneuploidy: a prospective, double-blind, randomized controlled pilot study, Anticancer Res, 24, 3121

2009, High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis, Hepatology, 50, 808, 10.1002/hep.23082

1999, Recurrence of primary sclerosing cholangitis following liver transplantation, Hepatology, 29, 1050, 10.1002/hep.510290427

2004, Inflammatory bowel diseases, 5-aminosalicylic acid and sulfasalazine treatment and risk of acute pancreatitis: a population-based case-control study, Am J Gastroenterol, 99, 884, 10.1111/j.1572-0241.2004.04123.x

1999, Risk of acute pancreatitis in patients with chronic inflammatory bowel disease. A Danish 16-year nationwide follow-up study, Scand J Gastroenterol, 34, 199, 10.1080/00365529950173096

2007, Mutations in clotting factors and inflammatory bowel disease, Am J Gastroenterol, 102, 338, 10.1111/j.1572-0241.2006.00974.x

2004, Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?, Gut, 53, 542, 10.1136/gut.2003.025411

2008, Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients, Am J Gastroenterol, 103, 2272, 10.1111/j.1572-0241.2008.02052.x

2010, Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism, Gastroenterology, 139, 779, 10.1053/j.gastro.2010.05.026

2007, Meta-analysis: The utility and safety of heparin in the treatment of active ulcerative colitis, Aliment Pharmacol Ther, 26, 653, 10.1111/j.1365-2036.2007.03418.x

2014, Conventional risk factors and cardiovascular outcomes of patients with inflammatory bowel disease with confirmed coronary artery disease, Inflamm Bowel Dis, 20, 1593, 10.1097/MIB.0000000000000109

2014, Inflammatory bowel disease is associated with an increased risk of hospitalization for heart failure: a Danish Nationwide Cohort study, Circ Heart Fail, 7, 717, 10.1161/CIRCHEARTFAILURE.114.001152

2014, Increased risk of atrial fibrillation and stroke during active stages of inflammatory bowel disease: a nationwide study, Europace, 16, 477, 10.1093/europace/eut312

2014, Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis, Clin Gastroenterol Hepatol, 12, 382, 10.1016/j.cgh.2013.08.023

2014, Pulmonary manifestations of inflammatory bowel disease, World J Gastroenterol, 20, 13501, 10.3748/wjg.v20.i37.13501

Recommendations of the Advisory Committee on Immunization Practices [ACIP], 1993, use of vaccines and immune globulins for persons with altered immunocompetence, MMWR Recomm Rep, 42, 1

1965, Opportunistic infections. The concept of ‘opportunistic infections’, Proc R Soc Med, 58, 341

2013, Infection-related hospitalizations are associated with increased mortality in patients with inflammatory bowel diseases, J Crohns Colitis, 7, 107, 10.1016/j.crohns.2012.02.015

2014, Risks of infection among the older inflammatory bowel disease patients, Curr Treat Options Gastroenterol, 12, 283, 10.1007/s11938-014-0023-x

2014, Oral corticosteroids and the risk of serious infections in patients with elderly-onset inflammatory bowel diseases, Am J Gastroenterol, 109, 1795, 10.1038/ajg.2014.313

2011, The influence of systemic glucocorticoid therapy upon the risk of non-serious infection in older patients with rheumatoid arthritis: a nested case-control study, Ann Rheum Dis, 70, 956, 10.1136/ard.2010.144741

2008, Risk factors for opportunistic infections in patients with inflammatory bowel disease, Gastroenterology, 134, 929, 10.1053/j.gastro.2008.01.012

2012, A pooled analysis of infections, malignancy, and mortality in infliximab- and immunomodulator-treated adult patients with inflammatory bowel disease, Am J Gastroenterol, 107, 1051, 10.1038/ajg.2012.89

2013, A prospective analysis of the incidence of and risk factors for opportunistic infections in patients with inflammatory bowel disease, J Gastroenterol, 48, 595, 10.1007/s00535-012-0686-9

2011, Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease, Clin Gastroenterol Hepatol, 9, 30, 10.1016/j.cgh.2010.09.026

2002, Ageing and infection, Lancet Infect Dis, 2, 659, 10.1016/S1473-3099(02)00437-1

2013, Opportunistic infections with anti-tumor necrosis factor-α therapy in inflammatory bowel disease: meta-analysis of randomized controlled trials, Am J Gastroenterol, 108, 1268, 10.1038/ajg.2013.138

2015, Systematic review and meta-analysis: opportunistic infections and malignancies during treatment with anti-integrin antibodies in inflammatory bowel disease, Aliment Pharmacol Ther, 41, 1227, 10.1111/apt.13215

2010, Course of inflammatory bowel disease in patients infected with human immunodeficiency virus, Inflamm Bowel Dis, 16, 507, 10.1002/ibd.21077

2006, Safe and effective application of anti-TNF-alpha in a patient infected with HIV and concomitant Crohn’s disease, Gut, 55, 1670, 10.1136/gut.2006.101386

2009, Infliximab therapy for HIV positive Crohn’s disease: a case report, J Crohns Colitis, 3, 302, 10.1016/j.crohns.2009.06.002

2011, Safety of anti-tumour necrosis factor agents in patients with chronic hepatitis C infection: a systematic review, Rheumatology [Oxford], 50, 1700, 10.1093/rheumatology/ker190

1996, Diagnosis of human cytomegalovirus infections in the immunocompromised host, Clin Diagn Virol, 5, 181, 10.1016/0928-0197(96)00219-X

1998, Summary of the II International Symposium on Cytomegalovirus, Antiviral Res, 39, 141, 10.1016/S0166-3542(98)00044-8

2005, Infections in patients with rheumatoid arthritis treated with biologic agents, Arthritis Rheum, 52, 3403, 10.1002/art.21386

2011, Education and imaging: gastrointestinal: herpes simplex virus-associated erythema multiforme [HAEM] during infliximab treatment for ulcerative colitis, J Gastroenterol Hepatol, 26, 610, 10.1111/j.1440-1746.2011.06622.x

2007, Herpes simplex virus colitis complicating ulcerative colitis: A case report and brief review on superinfections, J Crohns Colitis, 1, 41, 10.1016/j.crohns.2007.06.004

2012, Investigating the pregnant woman exposed to a child with a rash, BMJ, 344, e1790, 10.1136/bmj.e1790

Centers for Disease Control and Prevention [CDC], 2010, Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices [ACIP], MMWR Recomm Rep, 59, 1

2012, Prior varicella zoster virus exposure in IBD patients treated by anti-TNFs and other immunomodulators: implications for serological testing and vaccination guidelines, Aliment Pharmacol Ther, 36, 145, 10.1111/j.1365-2036.2012.05150.x

2012, Varicella zoster virus infection in inflammatory bowel disease, Inflamm Bowel Dis, 18, 2392, 10.1002/ibd.22950

2013, Poor recall of prior exposure to varicella zoster, rubella, measles, or mumps in patients with IBD, Inflamm Bowel Dis, 19, 418, 10.1002/ibd.23027

2010, Serious infections in patients with inflammatory bowel disease receiving anti-tumor-necrosis-factor-alpha therapy: an Australian and New Zealand experience, J Gastroenterol Hepatol, 25, 1732, 10.1111/j.1440-1746.2010.06407.x

CESAME Study Group, 2009, Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study, Lancet, 374, 1617, 10.1016/S0140-6736(09)61302-7

1999, Acyclovir for treatment of infectious mononucleosis: a meta-analysis, Scand J Infect Dis, 31, 543, 10.1080/00365549950164409

2014, Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop [III], J Crohns Colitis, 8, 31, 10.1016/j.crohns.2013.04.006

2014, Non-colorectal intestinal tract carcinomas in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop [II], J Crohns Colitis, 8, 19, 10.1016/j.crohns.2013.04.009

2006, Abnormalities of uterine cervix in women with inflammatory bowel disease, World J Gastroenterol, 12, 6167, 10.3748/wjg.v12.i38.6167

WHO Working Group for Risk Factors for Severe H1N1pdm Infection, 2011, Risk factors for severe outcomes following 2009 influenza A [H1N1] infection: a global pooled analysis, PLoS Med, 8, e1001053, 10.1371/journal.pmed.1001053

2013, Incidence and characteristics of the 2009 influenza [H1N1] infections in inflammatory bowel disease patients, J Crohns Colitis, 7, 308, 10.1016/j.crohns.2012.06.019

Centers for Disease Control and Prevention, 2014, Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices [ACIP]—United States, 2014-15 influenza season, MMWR Morb Mortal Wkly Rep, 63, 691

2011, Disseminated Cryptococcus neoformans infection and Crohn’s disease in an immunocompetent patient, J Crohns Colitis, 5, 60, 10.1016/j.crohns.2010.08.003

2007, Vascular endothelial growth factor and cyclooxygenase-2 are overexpressed in ileal pouch-anal anastomosis, Dis Colon Rectum, 50, 650, 10.1007/s10350-006-0807-8

2008, Prophylaxis against Pneumocystis pneumonia in patients with inflammatory bowel disease: toward a standard of care, Inflamm Bowel Dis, 14, 106, 10.1002/ibd.20261

2006, Tuberculosis in patients receiving anti-TNF agents despite chemoprophylaxis, Int J Tuberc Lung Dis, 10, 1127

2001, Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent, N Engl J Med, 345, 1098, 10.1056/NEJMoa011110

2013, Listeria infection in patients on anti-TNF treatment: report of two cases and review of the literature, J Crohns Colitis, 7, 175, 10.1016/j.crohns.2012.04.018

Committee BTSSoC, 2005, BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment, Thorax, 60, 800, 10.1136/thx.2005.046797

2008, Review article: minimizing tuberculosis during anti-tumour necrosis factor-alpha treatment of inflammatory bowel disease, Aliment Pharmacol Ther, 27, 19, 10.1111/j.1365-2036.2007.03553.x

2012, Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: a prospective study, Inflamm Bowel Dis, 18, 1042, 10.1002/ibd.21800

2009, Severe Legionella pneumophila pneumonia following infliximab therapy in a patient with Crohn’s disease, Inflamm Bowel Dis, 15, 1240, 10.1002/ibd.20866

2008, Legionella spp. and Legionnaires’ disease, J Infect, 56, 1, 10.1016/j.jinf.2007.09.010

2008, Pneumonia due to Nocardia cyriacigeorgica in a patient with Crohn’s disease treated with infliximab, J Crohns Colitis, 2, 331, 10.1016/j.crohns.2008.05.003

2004, Cutaneous nocardiosis complicating management of Crohn’s disease with infliximab and prednisone, CMAJ, 171, 1063, 10.1503/cmaj.1040563

2016, Stool isolation of nocardia nova in two immunomodulated patients with inflammatory bowel diseases, J Clin Gastroenterol, 50, 92, 10.1097/MCG.0000000000000403

2010, Glucocorticoids are associated with increased risk of short-term mortality in hospitalized patients with Clostridium difficile-associated disease, Am J Gastroenterol, 105, 2040, 10.1038/ajg.2010.142

2007, Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain, Ann Surg, 245, 267, 10.1097/01.sla.0000236628.79550.e5

2014, Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis, J Crohns Colitis, 8, 1569, 10.1016/j.crohns.2014.08.006

2015, Diagnosis and treatment of Clostridium difficile in adults: a systematic review, JAMA, 313, 398, 10.1001/jama.2014.17103

OPT-80-003 Clinical Study Group, 2011, Fidaxomicin versus vancomycin for Clostridium difficile infection, N Engl J Med, 364, 422, 10.1056/NEJMoa0910812

2016, Recurrence of Clostridium difficile infection in patients with inflammatory bowel disease: the RECIDIVISM study, Am J Gastroenterol, 111, 1141, 10.1038/ajg.2016.187

Infectious Diseases Society of America, 2006, The practice of travel medicine: guidelines by the Infectious Diseases Society of America, Clin Infect Dis, 43, 1499, 10.1086/508782

2011, Immunogenecity of hepatitis A vaccine in pediatric patients with inflammatory bowel disease, Inflamm Bowel Dis, 17, 1117, 10.1002/ibd.21465

1997, Fertility and pregnancy in inflammatory bowel disease, Int J Gynaecol Obstet, 58, 229, 10.1016/S0020-7292(97)00088-X

2013, Systematic review: fertility in non-surgically treated inflammatory bowel disease, Aliment Pharmacol Ther, 38, 847, 10.1111/apt.12478

2013, Fecundity, pregnancy outcomes, and breastfeeding in patients with inflammatory bowel disease: a large cohort survey, Scand J Gastroenterol, 48, 427, 10.3109/00365521.2013.772229

2016, What factors might drive voluntary childlessness [VC] in women with IBD? does IBD-specific pregnancy-related knowledge matter?, J Crohns Colitis, 10, 1151, 10.1093/ecco-jcc/jjw078

2016, Use of immunomodulators and biologics before, during, and after pregnancy, Inflamm Bowel Dis, 22, 213, 10.1097/MIB.0000000000000596

1981, Incidence of sulphasalazine-induced male infertility, Gut, 22, 452, 10.1136/gut.22.6.452

1984, Reversible male infertility due to sulphasalazine: studies in man and rat, Gut, 25, 1078, 10.1136/gut.25.10.1078

1980, Psoriasis, methotrexate, and oligospermia, Arch Dermatol, 116, 215, 10.1001/archderm.1980.01640260091025

2015, Review article: the safety of therapeutic drugs in male inflammatory bowel disease patients wishing to conceive, Aliment Pharmacol Ther, 41, 821, 10.1111/apt.13142

2008, A prospective evaluation of sexual function and quality of life after ileal pouch-anal anastomosis, Dis Colon Rectum, 51, 1032, 10.1007/s10350-008-9248-x

1995, Social and sexual function following ileal pouch-anal anastomosis, Dis Colon Rectum, 38, 286, 10.1007/BF02055604

2015, In vitro fertilization is successful in women with ulcerative colitis and ileal pouch anal anastomosis, Am J Gastroenterol, 110, 792, 10.1038/ajg.2014.400

European Crohns and Colitis Organisation-ECCO-Study Group of Epidemiology Committee-EpiCom, 2013, The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO-EpiCom Study of 209 pregnant women, Aliment Pharmacol Ther, 38, 501, 10.1111/apt.12412

2016, The effects of active IBD during pregnancy in the era of novel IBD therapies, Am J Gastroenterol, 111, 1305, 10.1038/ajg.2016.254

2011, Congenital abnormalities and other birth outcomes in children born to women with ulcerative colitis in Denmark and Sweden, Inflamm Bowel Dis, 17, 795, 10.1002/ibd.21369

2010, Ulcerative colitis and pregnancy outcomes in an Asian population, Am J Gastroenterol, 105, 387, 10.1038/ajg.2009.562

2013, Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease, Clin Gastroenterol Hepatol, 11, 286, 10.1016/j.cgh.2012.11.011

Dutch Delta IBD Group, 2013, Effects of discontinuing anti-tumor necrosis factor therapy during pregnancy on the course of inflammatory bowel disease and neonatal exposure, Clin Gastroenterol Hepatol, 11, 318, 10.1016/j.cgh.2012.10.024

2007, Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California, Gastroenterology, 133, 1106, 10.1053/j.gastro.2007.07.019

European Crohns and Colitis Organisation [ECCO] Study Group of Epidemiologic Committee [EpiCom], 2011, Pregnancy outcome in inflammatory bowel disease: prospective European case-control ECCO-EpiCom study, 2003-2006, Aliment Pharmacol Ther, 34, 724, 10.1111/j.1365-2036.2011.04794.x

2014, IBD medications during pregnancy and lactation, Nat Rev Gastroenterol Hepatol, 11, 116, 10.1038/nrgastro.2013.135

Dutch Initiative on Crohn and Colitis, 2014, Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease, Gut, 63, 451, 10.1136/gutjnl-2012-303615

French Network of Regional Pharmacovigilance Centers, 2004, Low dose methotrexate in the first trimester of pregnancy: results of a French collaborative study, J Rheumatol, 31, 2360

Dutch Initiative on Crohn and Colitis, 2013, Long-term follow-up of children exposed intrauterine to maternal thiopurine therapy during pregnancy in females with inflammatory bowel disease, Aliment Pharmacol Ther, 38, 38, 10.1111/apt.12334

2016, Concentrations of adalimumab and infliximab in mothers and newborns, and effects on infection, Gastroenterology, 151, 110, 10.1053/j.gastro.2016.04.002

1998, Inflammatory bowel disease and pregnancy, Gastroenterol Clin North Am, 27, 213, 10.1016/S0889-8553(05)70354-X

2013, Medications as a potential source of exposure to phthalates among women of childbearing age, Reprod Toxicol, 37, 1, 10.1016/j.reprotox.2013.01.001

2011, Exposure to phthalates: reproductive outcome and children health. A review of epidemiological studies, Int J Occup Med Environ Health, 24, 115

2008, Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis, Reprod Toxicol, 25, 271, 10.1016/j.reprotox.2007.11.010

2008, Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes, Am J Gastroenterol, 103, 1203, 10.1111/j.1572-0241.2007.01756.x

2001, Safety and timing of nonobstetric abdominal surgery in pregnancy, Dig Surg, 18, 409, 10.1159/000050183

1997, Surgical treatment of acute manifestations of Crohn’s disease during pregnancy, J R Soc Med, 90, 64, 10.1177/014107689709000203

1998, The safety of mesalamine in human pregnancy: a prospective controlled cohort study, Gastroenterology, 114, 23, 10.1016/S0016-5085(98)70628-6

1998, Foetal outcome in women with inflammatory bowel disease treated during pregnancy with oral mesalazine microgranules, Aliment Pharmacol Ther, 12, 1101, 10.1046/j.1365-2036.1998.00417.x

2011, Long-term follow-up of babies exposed to azathioprine in utero and via breastfeeding, J Crohns Colitis, 5, 95, 10.1016/j.crohns.2010.10.005

1972, The transplacental passage of prednisone and prednisolone in pregnancy near term, J Pediatr, 81, 936, 10.1016/S0022-3476(72)80547-X

1985, Prednisolone excretion in human milk, J Pediatr, 106, 1008, 10.1016/S0022-3476(85)80259-6

2011, Detection of infliximab in breast milk of nursing mothers with inflammatory bowel disease, J Crohns Colitis, 5, 555, 10.1016/j.crohns.2011.05.006

2006, Safety of endoscopical procedures during pregnancy, Singapore Med J, 47, 525

1996, A study at 10 medical centers of the safety and efficacy of 48 flexible sigmoidoscopies and 8 colonoscopies during pregnancy with follow-up of fetal outcome and with comparison to control groups, Dig Dis Sci, 41, 2353, 10.1007/BF02100127

2015, A prospective study of the safety of lower gastrointestinal endoscopy during pregnancy in patients with inflammatory bowel disease, J Crohns Colitis, 9, 519, 10.1093/ecco-jcc/jjv079

1990, Midazolam and nitrazepam in the maternity ward: milk concentrations and clinical effects, Br J Clin Pharmacol, 30, 787, 10.1111/j.1365-2125.1990.tb05443.x

2006, Pharmacokinetics of midazolam, propofol, and fentanyl transfer to human breast milk, Clin Pharmacol Ther, 79, 549, 10.1016/j.clpt.2006.02.010

2001, The risk of colorectal cancer in ulcerative colitis: a meta-analysis, Gut, 48, 526, 10.1136/gut.48.4.526

2012, Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies, Clin Gastroenterol Hepatol, 10, 639, 10.1016/j.cgh.2012.01.010

2013, Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a Danish population-based cohort study, Am J Gastroenterol, 108, 1869, 10.1038/ajg.2013.249

2015, Forty-year analysis of colonoscopic surveillance program for neoplasia in ulcerative colitis: an updated overview, Am J Gastroenterol, 110, 1022, 10.1038/ajg.2015.65

Sydney IBD Cohort Study Group, 2014, Long-term follow-up reveals low incidence of colorectal cancer, but frequent need for resection, among Australian patients with inflammatory bowel disease, Clin Gastroenterol Hepatol, 12, 644, 10.1016/j.cgh.2013.05.017

2004, Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County, Clin Gastroenterol Hepatol, 2, 1088, 10.1016/S1542-3565(04)00543-9

2008, High frequency of early colorectal cancer in inflammatory bowel disease, Gut, 57, 1246, 10.1136/gut.2007.143453

2013, Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease, Gastroenterology, 145, 166, 10.1053/j.gastro.2013.03.044

2003, Gross versus microscopic pancolitis and the occurrence of neoplasia in ulcerative colitis, Inflamm Bowel Dis, 9, 351, 10.1097/00054725-200311000-00002

2015, Low-grade dysplasia in ulcerative colitis: risk factors for developing high-grade dysplasia or colorectal cancer, Am J Gastroenterol, 110, 1461, 10.1038/ajg.2015.248

2009, More right-sided IBD-associated colorectal cancer in patients with primary sclerosing cholangitis, Inflamm Bowel Dis, 15, 1331, 10.1002/ibd.20886

2010, Risk factors for neoplasia in inflammatory bowel disease patients with pancolitis, Am J Gastroenterol, 105, 2405, 10.1038/ajg.2010.248

2001, Increased colorectal neoplasia in chronic ulcerative colitis complicated by primary sclerosing cholangitis: fact or fiction?, Gut, 48, 430, 10.1136/gut.48.3.430

2012, Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: a Nordic multicenter study, Scand J Gastroenterol, 47, 1021, 10.3109/00365521.2012.685754

2014, Risk of cancer in patients with inflammatory bowel diseases: a nationwide population-based cohort study with 30 years of follow-up evaluation, Clin Gastroenterol Hepatol, 12, 265, 10.1016/j.cgh.2013.03.034

2006, Predictive and protective factors associated with colorectal cancer in ulcerative colitis: a case-control study, Gastroenterology, 130, 1941, 10.1053/j.gastro.2006.03.028

1998, Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case-control study, Gastroenterology, 115, 1079, 10.1016/S0016-5085(98)70077-0

2016, Multiyear patterns of serum inflammatory biomarkers and risk of colorectal neoplasia in patients with ulcerative colitis, Inflamm Bowel Dis, 22, 100, 10.1097/MIB.0000000000000587

1990, Colonoscopic surveillance in long-standing total ulcerative colitis–a 15-year follow-up study, Gastroenterology, 99, 1021, 10.1016/0016-5085(90)90622-8

2009, Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease, Br J Cancer, 101, 1671, 10.1038/sj.bjc.6605359

1998, Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study, Gut, 42, 711, 10.1136/gut.42.5.711

2000, Colorectal cancer prevention in ulcerative colitis: a case-control study, Aliment Pharmacol Ther, 14, 145, 10.1046/j.1365-2036.2000.00698.x

British Society of Gastroenterology; Association of Coloproctology for Great Britain and Ireland, 2010, Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups [update from 2002], Gut, 59, 666, 10.1136/gut.2009.179804

2006, Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis, Gastroenterology, 130, 1030, 10.1053/j.gastro.2005.12.035

1994, Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?, Lancet, 343, 71, 10.1016/S0140-6736(94)90813-3

2006, Incidence and prognosis of colorectal dysplasia in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota, Inflamm Bowel Dis, 12, 669, 10.1097/00054725-200608000-00001

2002, Low-grade dysplasia in extensive, long-standing inflammatory bowel disease: a follow-up study, Dis Colon Rectum, 45, 615, 10.1007/s10350-004-6255-4

1991, Dysplasia and carcinoma in longstanding ulcerative colitis: an endoscopic and histological surveillance programme, Gut, 32, 1521, 10.1136/gut.32.12.1521

2007, Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis, Aliment Pharmacol Ther, 25, 657, 10.1111/j.1365-2036.2007.03241.x

2003, Ten year follow up of ulcerative colitis patients with and without low grade dysplasia, Gut, 52, 1127, 10.1136/gut.52.8.1127

2004, Most dysplasia in ulcerative colitis is visible at colonoscopy, Gastrointest Endosc, 60, 334, 10.1016/S0016-5107(04)01710-9

2002, Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis, Gastrointest Endosc, 56, 48, 10.1067/mge.2002.125367

1989, Observer study of the grading of dysplasia in ulcerative colitis: comparison with clinical outcome, Hum Pathol, 20, 1008, 10.1016/0046-8177(89)90273-6

2006, Judgement of the quality of bowel preparation at screening flexible sigmoidoscopy is associated with variability in adenoma detection rates, Endoscopy, 38, 456, 10.1055/s-2006-925259

2013, Comparison of high definition with standard white light endoscopy for detection of dysplastic lesions during surveillance colonoscopy in patients with colonic inflammatory bowel disease, Inflamm Bowel Dis, 19, 350, 10.1002/ibd.23002

2016, Comparison of targeted vs random biopsies for surveillance of ulcerative colitis-associated colorectal cancer, Gastroenterology, 151, 1122, 10.1053/j.gastro.2016.08.002

2011, Colorectal cancer screening in patients with ulcerative and Crohn’s colitis with use of colonoscopy, chromoendoscopy and confocal endomicroscopy, Eur J Gastroenterol Hepatol, 23, 680, 10.1097/MEG.0b013e32834791b4

2003, Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis, Gastroenterology, 124, 880, 10.1053/gast.2003.50146

2005, Indigo carmine-assisted high-magnification chromoscopic colonoscopy for the detection and characterisation of intraepithelial neoplasia in ulcerative colitis: a prospective evaluation, Endoscopy, 37, 1186, 10.1055/s-2005-921032

2007, Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis, Gastroenterology, 132, 874, 10.1053/j.gastro.2007.01.048

2011, Meta-analysis: the diagnostic yield of chromoendoscopy for detecting dysplasia in patients with colonic inflammatory bowel disease, Aliment Pharmacol Ther, 33, 304, 10.1111/j.1365-2036.2010.04525.x

2012, The diagnostic accuracy of chromoendoscopy for dysplasia in ulcerative colitis: meta-analysis of six randomized controlled trials, Colorectal Dis, 14, 416, 10.1111/j.1463-1318.2010.02505.x

2016, Real-life chromoendoscopy for neoplasia detection and characterisation in long-standing IBD, Gut

2007, Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis, Endoscopy, 39, 216, 10.1055/s-2007-966214

2012, Narrow band imaging for detection of dysplasia in colitis: a randomized controlled trial, Am J Gastroenterol, 107, 885, 10.1038/ajg.2012.67

2011, Narrow-band imaging as an alternative to chromoendoscopy for the detection of dysplasia in long-standing inflammatory bowel disease: a prospective, randomized, crossover study, Gastrointest Endosc, 74, 840, 10.1016/j.gie.2011.05.013

2011, Surveillance colonoscopy in patients with inflammatory bowel disease: comparison of random biopsy vs. targeted biopsy protocols, Int J Colorectal Dis, 26, 667, 10.1007/s00384-011-1130-y

2011, Pilot study of probe-based confocal laser endomicroscopy during colonoscopic surveillance of patients with longstanding ulcerative colitis, Endoscopy, 43, 116, 10.1055/s-0030-1255954

1997, The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis, Gastroenterology, 112, 29, 10.1016/S0016-5085(97)70215-4

2001, Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study, Dis Colon Rectum, 44, 77, 10.1007/BF02234825

1996, Long-term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis: a retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire, Eur J Gastroenterol Hepatol, 8, 1179, 10.1097/00042737-199612000-00009

1994, Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study, Gastroenterology, 107, 117, 10.1016/0016-5085(94)90068-X

2003, Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer?, Am J Gastroenterol, 98, 2784, 10.1111/j.1572-0241.2003.08718.x

2006, Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis, Clin Gastroenterol Hepatol, 4, 1346, 10.1016/j.cgh.2006.08.014

2007, Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen county, Denmark and Olmsted county, Minnesota, Am J Gastroenterol, 102, 829, 10.1111/j.1572-0241.2007.01070.x

2005, 5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study, Gut, 54, 1573, 10.1136/gut.2005.070896

2007, 5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease, Inflamm Bowel Dis, 13, 367, 10.1002/ibd.20074

2011, 5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study, Am J Gastroenterol, 106, 731, 10.1038/ajg.2011.50

2012, 5-aminosalicylic acid is not protective against colorectal cancer in inflammatory bowel disease: a meta-analysis of non-referral populations, Am J Gastroenterol, 107, 1298, 10.1038/ajg.2012.198

2009, Thiopurine therapy is associated with a three-fold decrease in the incidence of advanced colorectal neoplasia in IBD patients with longstanding extensive colitis: results from the CESAME cohort, Gastroenterology, 136, A-54

2004, Diagnosis and management of dysplasia in patients with inflammatory bowel diseases, Gastroenterology, 126, 1634, 10.1053/j.gastro.2004.03.025

2010, Systematic review: molecular chemoprevention of colorectal malignancy by mesalazine, Aliment Pharmacol Ther, 31, 202, 10.1111/j.1365-2036.2009.04195.x

2008, Progression to colorectal neoplasia in ulcerative colitis: effect of mesalamine, Clin Gastroenterol Hepatol, 6, 1225, 10.1016/j.cgh.2008.05.020

2010, Azathioprine [AZA] is associated with less histological inflammation of the colon in inactive IBD, Gastroenterology, 138, S-693

2001, Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis, Ann Intern Med, 134, 89, 10.7326/0003-4819-134-2-200101160-00008

2005, Chemoprevention of colorectal neoplasia in ulcerative colitis: the effect of 6-mercaptopurine, Clin Gastroenterol Hepatol, 3, 1015, 10.1016/S1542-3565(05)00738-X

2012, Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease, Gut, 61, 235, 10.1136/gut.2011.237412

2014, Thiopurines and risk of colorectal neoplasia in patients with inflammatory bowel disease: a meta-analysis, Clin Gastroenterol Hepatol, 12, 1793, 10.1016/j.cgh.2014.05.019

CESAME study group, 2016, Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study, Aliment Pharmacol Ther, 43, 252, 10.1111/apt.13466

CESAME Study Group, 2014, Increased risk of acute myeloid leukemias and myelodysplastic syndromes in patients who received thiopurine treatment for inflammatory bowel disease, Clin Gastroenterol Hepatol, 12, 1324, 10.1016/j.cgh.2014.02.026

Cesame Study Group, 2011, Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease, Gastroenterology, 141, 1621, 10.1053/j.gastro.2011.06.050

2013, Effect of ursodeoxycholic acid use on the risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a systematic review and meta-analysis, Inflamm Bowel Dis, 19, 1631, 10.1097/MIB.0b013e318286fa61

2004, Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis, Gut, 53, 256, 10.1136/gut.2003.016386

1999, Adenomas and adenoma-like DALMs in chronic ulcerative colitis: a clinical, pathological, and molecular review, Am J Gastroenterol, 94, 1746, 10.1111/j.1572-0241.1999.01201.x

1983, Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications, Hum Pathol, 14, 931, 10.1016/S0046-8177(83)80175-0

1996, Significance and detection of dysplasia in chronic colitis, Cancer, 78, 2261, 10.1002/(SICI)1097-0142(19961201)78:11<2261::AID-CNCR1>3.0.CO;2-Q

2002, Interobserver variability in the diagnosis of ulcerative colitis-associated dysplasia by telepathology, Mod Pathol, 15, 379, 10.1038/modpathol.3880534

2001, Inter-observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis, J Pathol, 194, 152, 10.1002/path.876

SCENIC Guideline Development Panel, 2015, SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease, Gastroenterology, 148, 639, 10.1053/j.gastro.2015.01.031

1981, Dysplasia-associated lesion or mass [DALM] detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy, Gastroenterology, 80, 366, 10.1016/0016-5085(81)90727-7

1990, Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years, Gut, 31, 800, 10.1136/gut.31.7.800

1983, Macroscopic lesions in dysplasia and carcinoma complicating ulcerative colitis, Dig Dis Sci, 28, 18, 10.1007/BF01393356

2006, Sporadic adenoma in ulcerative colitis: endoscopic resection is an adequate treatment, Gut, 55, 1151

1998, Polypoid dysplasia and adenomas in inflammatory bowel disease: a clinical, pathologic, and follow-up study of 89 polyps from 59 patients, Am J Surg Pathol, 22, 275, 10.1097/00000478-199803000-00001

1998, Differential diagnosis of dysplasia-associated lesion or mass and coincidental adenoma in ulcerative colitis, Dis Colon Rectum, 41, 322, 10.1007/BF02237486

2004, Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis, Clin Gastroenterol Hepatol, 2, 534, 10.1016/S1542-3565(04)00237-X

1999, Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps, Gastroenterology, 117, 1295, 10.1016/S0016-5085(99)70279-9

2014, Cancer risk after resection of polypoid dysplasia in patients with longstanding ulcerative colitis: a meta-analysis, Clin Gastroenterol Hepatol, 12, 756, 10.1016/j.cgh.2013.07.024

2010, When should ulcerative colitis patients undergo colectomy for dysplasia? Mismatch between patient preferences and physician recommendations, Inflamm Bowel Dis, 16, 1658, 10.1002/ibd.21233

1999, Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis, Gastroenterology, 117, 1288, 10.1016/S0016-5085(99)70278-7

2003, Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis, Gastroenterology, 125, 1311, 10.1016/j.gastro.2003.08.023

2005, Thirty years of experience living with a continent ileostomy: bad restrooms–not my reservoir–decide my life, J Wound Ostomy Continence Nurs, 32, 321, 10.1097/00152192-200509000-00010

2001, Patient quality of life after successful restorative proctocolectomy is normal, Colorectal Dis, 3, 223, 10.1046/j.1463-1318.2001.00228.x

2003, Quality of life before and after proctocolectomy and IPAA in patients with ulcerative proctocolitis–a prospective study, Colorectal Dis, 5, 173, 10.1046/j.1463-1318.2003.00455.x

2010, Delayed surgery for acute severe colitis is associated with increased risk of postoperative complications, Br J Surg, 97, 404, 10.1002/bjs.6874

2003, Subtotal colectomy for severe acute colitis: a 20-year experience of a tertiary care center with an aggressive and early surgical policy, J Am Coll Surg, 197, 379, 10.1016/S1072-7515(03)00434-4

2002, Acute surgical emergencies in inflammatory bowel disease, Am J Surg, 184, 45, 10.1016/S0002-9610(02)00879-6

2005, Urgent subtotal colectomy for severe inflammatory bowel disease, Dis Colon Rectum, 48, 70, 10.1007/s10350-004-0750-5

2013, Prolonged preoperative hospital stay is a risk factor for complications after emergency colectomy for severe colitis, Colorectal Dis, 15, 1392, 10.1111/codi.12328

2009, Minimally invasive subtotal colectomy and ileal pouch-anal anastomosis for fulminant ulcerative colitis: a reasonable approach?, Dis Colon Rectum, 52, 187, 10.1007/DCR.0b013e31819a5cc1

2007, Laparoscopic subtotal colectomy for acute or severe colitis complicating inflammatory bowel disease: a case-matched study in 88 patients, Surgery, 141, 640, 10.1016/j.surg.2006.12.012

1995, Colectomy for acute colitis: is it safe to close the rectal stump?, Int J Colorectal Dis, 10, 222, 10.1007/BF00346223

1991, Subtotal colectomy for ulcerative colitis: complications related to the rectal remnant, Dis Colon Rectum, 34, 1005, 10.1007/BF02049965

1994, Does the level of stapled ileoanal anastomosis influence physiologic and functional outcome?, Dis Colon Rectum, 37, 321, 10.1007/BF02053591

2006, A comparison of hand-sewn versus stapled ileal pouch anal anastomosis [IPAA] following proctocolectomy: a meta-analysis of 4183 patients, Ann Surg, 244, 18

2009, Comparison of outcomes after hand-sewn versus stapled ileal pouch-anal anastomosis in 3,109 patients, Surgery, 146, 723, 10.1016/j.surg.2009.06.041

1983, Fate of the rectal mucosa after rectal mucosectomy and ileoanal anastomosis, Dis Colon Rectum, 26, 768, 10.1007/BF02554744

2010, Oncologic outcome in patients with ulcerative colitis associated with dyplasia or cancer who underwent stapled or handsewn ileal pouch-anal anastomosis, Dis Colon Rectum, 53, 1495, 10.1007/DCR.0b013e3181f222d5

2007, Systematic review of dysplasia after restorative proctocolectomy for ulcerative colitis, Br J Surg, 94, 534, 10.1002/bjs.5811

2004, The risk of dysplasia and cancer in the ileal pouch mucosa after restorative proctocolectomy for ulcerative proctocolitis is low: a long-term term follow-up study, Colorectal Dis, 6, 494, 10.1111/j.1463-1318.2004.00716.x

2001, One- or two-stage procedure for restorative proctocolectomy: rationale for a surgical strategy in ulcerative colitis, Ann Surg, 234, 788, 10.1097/00000658-200112000-00010

2004, A prospective audit of the complications of loop ileostomy construction and takedown, Dig Surg, 21, 440, 10.1159/000083471

2008, Comparison of outcomes after restorative proctocolectomy with or without defunctioning ileostomy, Arch Surg, 143, 406, 10.1001/archsurg.143.4.406

1998, Selective omission of loop ileostomy in restorative proctocolectomy, Int J Colorectal Dis, 13, 119, 10.1007/s003840050148

1991, Ileal pouch-anal anastomosis without ileostomy, Dis Colon Rectum, 34, 870, 10.1007/BF02049699

2002, Ileal pouch anal-anastomosis without protective ileostomy, Gastroenterol Clin Biol, 26, 671

2011, To divert or not to divert: a retrospective analysis of variables that influence ileostomy omission in ileal pouch surgery, Arch Surg, 146, 82, 10.1001/archsurg.2010.304

2005, Evaluation of the learning curve in ileal pouch-anal anastomosis surgery, Ann Surg, 241, 262, 10.1097/01.sla.0000152018.99541.f1

2011, Volume analysis of outcome following restorative proctocolectomy, Br J Surg, 98, 408, 10.1002/bjs.7312

2007, Improved outcome due to increased experience and individualized management of leaks after ileal pouch-anal anastomosis, Ann Surg, 246, 763, 10.1097/SLA.0b013e31814539b1

2003, Long-term failure after restorative proctocolectomy for ulcerative colitis, Ann Surg, 238, 229, 10.1097/01.sla.0000082121.84763.4c

2004, Results of surgical removal of the pouch after failed restorative proctocolectomy, Dis Colon Rectum, 47, 869, 10.1007/s10350-004-0536-9

2004, The failed pelvic pouch: conversion to a continent ileostomy, Tech Coloproctol, 8, 102

2004, Functional outcome and quality of life after repeat ileal pouch-anal anastomosis for complications of ileoanal surgery, Dis Colon Rectum, 47, 2, 10.1007/s10350-003-0003-z

1995, Ileal pouch-anal anastomoses complications and function in 1005 patients, Ann Surg, 222, 120, 10.1097/00000658-199508000-00003

1994, Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment, Gastroenterology, 107, 1856, 10.1016/0016-5085(94)90832-X

2011, How to manage pouchitis in ulcerative colitis?, Curr Drug Targets, 12, 1454, 10.2174/138945011796818144

1996, Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy, Arch Surg, 131, 497, 10.1001/archsurg.1996.01430170043007

1998, J ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcome in 1310 patients, Br J Surg, 85, 800, 10.1046/j.1365-2168.1998.00689.x

1996, Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis, Gut, 38, 234, 10.1136/gut.38.2.234

2000, Risk factors and true incidence of pouchitis in patients after ileal pouch-anal anastomoses, World J Surg, 24, 851, 10.1007/s002680010136

2005, Comprehensive evaluation of inflammatory and noninflammatory sequelae of ileal pouch-anal anastomoses, Am J Gastroenterol, 100, 93, 10.1111/j.1572-0241.2005.40778.x

2004, Sexuality in patients with ulcerative colitis before and after restorative proctocolectomy: a prospective study, Scand J Gastroenterol, 39, 374, 10.1080/00365520310008449

1999, Fertility after ileal pouch-anal anastomosis in women with ulcerative colitis, Br J Surg, 86, 493, 10.1046/j.1365-2168.1999.01076.x

2002, Ulcerative colitis: female fecundity before diagnosis, during disease, and after surgery compared with a population sample, Gastroenterology, 122, 15, 10.1053/gast.2002.30345

2004, Fertility is reduced after restorative proctocolectomy with ileal pouch anal anastomosis: a study of 300 patients, Surgery, 136, 795, 10.1016/j.surg.2004.06.018

2004, Female infertility after ileal pouch-anal anastomosis for ulcerative colitis, Dis Colon Rectum, 47, 1119, 10.1007/s10350-004-0570-7

1994, Gynaecological and sexual function related to anatomical changes in the female pelvis after restorative proctocolectomy, Int J Colorectal Dis, 9, 77, 10.1007/BF00699417

2013, A total laparoscopic approach reduces the infertility rate after ileal pouch-anal anastomosis: a 2-center study, Ann Surg, 258, 275, 10.1097/SLA.0b013e3182813741

2012, Less adhesiolysis and hernia repair during completion proctocolectomy after laparoscopic emergency colectomy for ulcerative colitis, Surg Endosc, 26, 368, 10.1007/s00464-011-1880-1

2009, Effect of perioperative immunosuppressive medication on early outcome in Crohn’s disease patients, World J Surg, 33, 1049, 10.1007/s00268-009-9957-x

2012, Significantly increased pregnancy rates after laparoscopic restorative proctocolectomy: a cross-sectional study, Ann Surg, 256, 1045, 10.1097/SLA.0b013e318250caa9

2006, Colectomy with ileorectal anastomosis preserves female fertility in ulcerative colitis, Gastroenterol Clin Biol, 30, 594, 10.1016/S0399-8320(06)73233-X

2003, Female fecundity before and after operation for familial adenomatous polyposis, Br J Surg, 90, 227, 10.1002/bjs.4082

2006, The place for colectomy and ileorectal anastomosis: a valid surgical option for ulcerative colitis?, Tech Coloproctol, 10, 237, 10.1007/s10151-006-0286-x

2010, Clinical outcomes of ileorectal anastomosis for ulcerative colitis, Br J Surg, 97, 65

2011, Sexual and urinary functioning after rectal surgery: a prospective comparative study with a median follow-up of 8.5 years, Int J Colorectal Dis, 26, 1549, 10.1007/s00384-011-1288-3

2003, Obstetric sphincter tears and anal incontinence: an observational follow-up study, Acta Obstet Gynecol Scand, 82, 921, 10.1034/j.1600-0412.2003.00260.x

1996, Incidence of third-degree perineal tears in labour and outcome after primary repair, Br J Surg, 83, 218, 10.1002/bjs.1800830220

1990, Effect of vaginal delivery on the pelvic floor: a 5-year follow-up, Br J Surg, 77, 1358, 10.1002/bjs.1800771213

1984, Injury to innervation of pelvic floor sphincter musculature in childbirth, Lancet, 2, 546

2004, Pregnancy and delivery before and after ileal pouch-anal anastomosis for inflammatory bowel disease: immediate and long-term consequences and outcomes, Dis Colon Rectum, 47, 1127, 10.1007/s10350-004-0569-0

2005, Vaginal delivery after ileal pouch-anal anastomosis: a word of caution, Dis Colon Rectum, 48, 1691, 10.1007/s10350-005-0124-7

2007, The effect of restorative proctocolectomy on sexual function, urinary function, fertility, pregnancy and delivery: a systematic review, Dis Colon Rectum, 50, 1128, 10.1007/s10350-007-0240-7

2006, Effect of vaginal delivery on long-term pouch function, Br J Surg, 93, 1394, 10.1002/bjs.5467

2011, Ileal pouch-anal anastomosis in elderly patients: is there a difference in morbidity compared with younger patients?, Colorectal Dis, 13, 177, 10.1111/j.1463-1318.2009.02097.x

2005, Ileal pouch-anal anastomosis: does age at the time of surgery affect outcome?, Arch Surg, 140, 534, 10.1001/archsurg.140.6.534

2000, Functional outcome and quality of life in an elderly patient with an ileal pouch-anal anastomosis: a 10-year follow up, Aust N Z J Surg, 70, 906, 10.1046/j.1440-1622.2000.02006.x

2002, Functional outcome, quality of life, and complications after ileal pouch-anal anastomosis in selected septuagenarians, Dis Colon Rectum, 45, 890, 10.1007/s10350-004-6323-9

2011, Influence of age at ileoanal pouch creation on long-term changes in functional outcomes, Colorectal Dis, 13, 184, 10.1111/j.1463-1318.2009.02127.x

1997, Ileo-anal pouch function and dysfunction, Dig Dis, 15, 172, 10.1159/000171597

2001, Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis, Gastroenterology, 121, 261, 10.1053/gast.2001.26290

2004, Treatment of rectal cuff inflammation [cuffitis] in patients with ulcerative colitis following restorative proctocolectomy and ileal pouch-anal anastomosis, Am J Gastroenterol, 99, 1527, 10.1111/j.1572-0241.2004.30518.x

1990, Long-term results of ileorectal anastomosis in ulcerative colitis in Stockholm County, Dis Colon Rectum, 33, 195, 10.1007/BF02134178

2005, Fate of the rectum after colectomy with ileorectal anastomosis in ulcerative colitis, Scand J Surg, 94, 40, 10.1177/145749690509400110

2005, Results and complications after ileal pouch anal anastomosis: a meta-analysis of 43 observational studies comprising 9,317 patients, Dig Surg, 22, 69, 10.1159/000085356

1996, Disconnection, pouch revision and reconnection of the ileal pouch-anal anastomosis, Br J Surg, 83, 1401, 10.1002/bjs.1800831025

2006, Causes and outcomes of pouch excision after restorative proctocolectomy, Br J Surg, 93, 82, 10.1002/bjs.5147

2002, Risk of small bowel obstruction after the ileal pouch-anal anastomosis, Ann Surg, 235, 200, 10.1097/00000658-200202000-00007

1999, Reconstruction for chronic dysfunction of ileoanal pouches, Ann Surg, 229, 197, 10.1097/00000658-199902000-00006

2012, Intraoperative, postoperative and reoperative problems with ileoanal pouches, Br J Surg, 99, 454, 10.1002/bjs.8697

1996, Salvage surgery for ileal pouch outlet obstruction, Br J Surg, 83, 368, 10.1002/bjs.1800830324

2013, Transperineal perineal ultrasound versus magnetic resonance imaging in the assessment of perianal Crohn’s disease, Inflamm Bowel Dis, 19, 2737, 10.1097/01.MIB.0000436274.95722.e5

2009, Guide to endoscopy of the ileo-anal pouch following restorative proctocolectomy with ileal pouch-anal anastomosis; indications, technique, and management of common findings, Inflamm Bowel Dis, 15, 1256, 10.1002/ibd.20874

2010, Ileal pouch-anal anastomosis surgery: imaging and intervention for post-operative complications, Radiographics, 30, 221, 10.1148/rg.301095084

2009, Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis, Inflamm Bowel Dis, 15, 1062, 10.1002/ibd.20863

2004, Effect of high-dose steroids on anastomotic complications after proctocolectomy with ileal pouch-anal anastomosis, J Gastrointest Surg, 8, 547, 10.1016/j.gassur.2004.01.002

2003, Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients, Gastroenterology, 125, 320, 10.1016/S0016-5085(03)00883-7

2002, Azathioprine or 6-mercaptopurine before colectomy for ulcerative colitis is not associated with increased postoperative complications, Inflamm Bowel Dis, 8, 311, 10.1097/00054725-200209000-00001

2008, Preoperative steroid use and risk of postoperative complications in patients with inflammatory bowel disease undergoing abdominal surgery, Am J Gastroenterol, 103, 2373, 10.1111/j.1572-0241.2008.01942.x

2006, Systematic review of postoperative complications in patients with inflammatory bowel disease treated with immunomodulators, Br J Surg, 93, 793, 10.1002/bjs.5375

2007, Should ileoanal pouch surgery be staged for patients with mucosal ulcerative colitis on immunosuppressives?, Int J Colorectal Dis, 22, 289, 10.1007/s00384-006-0168-8

2010, Postoperative outcome of colectomy for pediatric patients with ulcerative colitis, J Pediatr Gastroenterol Nutr, 51, 151, 10.1097/MPG.0b013e3181c99290

2007, Pouch outcomes among children with ulcerative colitis treated with calcineurin inhibitors before ileal pouch anal anastomosis surgery, J Pediatr Surg, 42, 31, 10.1016/j.jpedsurg.2006.09.006

2016, Tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis: a retrospective observational study, Aliment Pharmacol Ther, 43, 705, 10.1111/apt.13531

2010, Meta-analysis: preoperative infliximab treatment and short-term post-operative complications in patients with ulcerative colitis, Aliment Pharmacol Ther, 31, 486, 10.1111/j.1365-2036.2009.04204.x

2005, Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study, Gastroenterology, 128, 1805, 10.1053/j.gastro.2005.03.003

2007, Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis, J Am Coll Surg, 204, 956, 10.1016/j.jamcollsurg.2006.12.044

2007, Does infliximab influence surgical morbidity of ileal pouch-anal anastomosis in patients with ulcerative colitis?, Dis Colon Rectum, 50, 1747, 10.1007/s10350-007-9008-3

2008, Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy, Dis Colon Rectum, 51, 1202, 10.1007/s10350-008-9364-7

2010, Preoperative infliximab treatment and postoperative complications after laparoscopic restorative proctocolectomy with ileal pouch-anal anastomosis: a case-matched study, Surg Endosc, 24, 1866, 10.1007/s00464-009-0861-0

2010, Preoperative infliximab treatment in patients with ulcerative and indeterminate colitis does not increase rate of conversion to emergent and multistep abdominal surgery, Int J Colorectal Dis, 25, 401, 10.1007/s00384-009-0800-5

2011, Anti-TNF-alpha therapies do not increase early postoperative complications in patients with inflammatory bowel disease. An Italian single-center experience, Int J Colorectal Dis, 26, 1435, 10.1007/s00384-011-1236-2

2013, Previous infliximab therapy and postoperative complications after proctocolectomy with ileum pouch anal anastomosis, J Crohns Colitis, 7, 142, 10.1016/j.crohns.2012.03.013

2013, Preoperative use of anti-TNF-α agents and the risk of post-operative complications in patients with Crohn’s disease–a nationwide cohort study, Aliment Pharmacol Ther, 37, 214, 10.1111/apt.12159

2010, Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis, Gut, 59, 49, 10.1136/gut.2009.183095

2008, Long-term outcome after infliximab for refractory ulcerative colitis, J Crohns Colitis, 2, 219, 10.1016/j.crohns.2008.03.004

2009, Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab, Gastroenterology, 137, 1250, 10.1053/j.gastro.2009.06.061

2008, Cyclosporine and infliximab as rescue therapy for each other in patients with steroid-refractory ulcerative colitis, Clin Gastroenterol Hepatol, 6, 1112, 10.1016/j.cgh.2008.04.035

GETAID, 2011, Successive treatment with cyclosporine and infliximab in steroid-refractory ulcerative colitis, Am J Gastroenterol, 106, 771, 10.1038/ajg.2011.62

2009, Infliximab rescue therapy after cyclosporin failure in steroid-refractory ulcerative colitis, Digestion, 80, 30, 10.1159/000212075

1996, Pouchitis following pelvic pouch operation for ulcerative colitis. Incidence, cumulative risk, and risk factors, Dis Colon Rectum, 39, 1012, 10.1007/BF02054692

1993, Incidence and characteristics of pouchitis in the Kock continent ileostomy and the pelvic pouch, Scand J Gastroenterol, 28, 695, 10.3109/00365529309098275

1993, Function of ileal J pouch-anal anastomosis in patients with familial adenomatous polyposis, Br J Surg, 80, 765, 10.1002/bjs.1800800638

1993, Similar functional results after restorative proctocolectomy in patients with familial adenomatous polyposis and mucosal ulcerative colitis, Am J Surg, 165, 322, 10.1016/S0002-9610(05)80834-7

1986, Restorative proctocolectomy with ileal reservoir, Int J Colorectal Dis, 1, 2, 10.1007/BF01648830

1993, Long-term results of the ileoanal pouch procedure, Arch Surg, 128, 500, 10.1001/archsurg.1993.01420170030003

1988, Pouchitis, Int J Colorectal Dis, 3, 226, 10.1007/BF01660720

1993, The problem with pouchitis, Gastroenterology, 104, 1209, 10.1016/0016-5085(93)90296-O

1989, Pouchitis, Int J Colorectal Dis, 4, 205, 10.1007/BF01644986

2002, Irritable pouch syndrome: a new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis, Am J Gastroenterol, 97, 972, 10.1111/j.1572-0241.2002.05617.x

2008, Endoscopy in the management of patients after ileal pouch surgery for ulcerative colitis, Endoscopy, 40, 529, 10.1055/s-2007-995784

1986, An assessment of inflammation in the reservoir after restorative proctocolectomy with ileoanal ileal reservoir, Int J Colorectal Dis, 1, 167, 10.1007/BF01648445

1987, Restorative proctocolectomy with ileal reservoir: pathological and histochemical study of mucosal biopsy specimens, J Clin Pathol, 40, 601, 10.1136/jcp.40.6.601

1998, Patterns of distribution of endoscopic and histological changes in the ileal reservoir after restorative proctocolectomy for ulcerative colitis. A long-term follow-up study, Int J Colorectal Dis, 13, 103, 10.1007/s003840050144

1993, Distribution of mucosal pathology and an assessment of colonic phenotypic change in the pelvic ileal reservoir, Gut, 34, 101, 10.1136/gut.34.1.101

1994, Pouchitis: result of microbial imbalance?, Gut, 35, 658, 10.1136/gut.35.5.658

2003, Tropomyosin expression in the ileal pouch: a relationship with the development of pouchitis in ulcerative colitis, Am J Gastroenterol, 98, 2719, 10.1111/j.1572-0241.2003.08719.x

2006, Systematic review: the management of pouchitis, Aliment Pharmacol Ther, 23, 1087, 10.1111/j.1365-2036.2006.02884.x

2006, Risk factors for diseases of ileal pouch-anal anastomosis after restorative proctocolectomy for ulcerative colitis, Clin Gastroenterol Hepatol, 4, 81, 10.1016/j.cgh.2005.10.004

2006, Clostridium difficile-associated pouchitis, Dig Dis Sci, 51, 2361, 10.1007/s10620-006-9172-7

2006, Pre-pouch ileitis: a disease of the ileum in ulcerative colitis after restorative proctocolectomy, Colorectal Dis, 8, 402, 10.1111/j.1463-1318.2006.00954.x

2007, Effect of withdrawal of nonsteroidal anti-inflammatory drug use on ileal pouch disorders, Dig Dis Sci, 52, 3321, 10.1007/s10620-006-9710-3

2012, Etiology of pouchitis, Inflamm Bowel Dis, 18, 1146, 10.1002/ibd.21911

1998, Preoperative terminal ileal and colonic resection histopathology predicts risk of pouchitis in patients after ileoanal pull-through procedure, Ann Surg, 227, 654, 10.1097/00000658-199805000-00006

1990, Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis, Ann Surg, 211, 622

2005, Differentiating risk factors for acute and chronic pouchitis, Clin Gastroenterol Hepatol, 3, 60, 10.1016/S1542-3565(04)00604-4

2001, The interleukin 1 receptor antagonist gene allele 2 as a predictor of pouchitis following colectomy and IPAA in ulcerative colitis, Gastroenterology, 121, 805, 10.1053/gast.2001.28017

2001, High level perinuclear antineutrophil cytoplasmic antibody [pANCA] in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis, Gut, 49, 671, 10.1136/gut.49.5.671

2011, Irritable pouch syndrome is characterized by visceral hypersensitivity, Inflamm Bowel Dis, 17, 994, 10.1002/ibd.21412

2011, Perioperative factors during ileal pouch-anal anastomosis predict pouchitis, Dis Colon Rectum, 54, 311, 10.1007/DCR.0b013e3181fded4d

Pouchitis: risk factors, frequency, natural history, classification and public health perspective. In: Trends in Inflammatory Bowel Disease 1996, 51

2009, Clinical guidelines for the management of pouchitis, Inflamm Bowel Dis, 15, 1424, 10.1002/ibd.21039

2001, A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis, Inflamm Bowel Dis, 7, 301, 10.1097/00054725-200111000-00004

1994, Pouchitis after ileal pouch-anal anastomosis: a pouchitis disease activity index, Mayo Clin Proc, 69, 409, 10.1016/S0025-6196(12)61634-6

2001, Comparison of the Moskowitz criteria and the pouchitis disease activity index [PDAI] for diagnosis of ileoanal pouch inflammation, Colorectal Dis, 3, 161, 10.1046/j.1463-1318.2001.00211.x

2002, Diagnosing pouchitis: comparative validation of two scoring systems in routine follow-up, Dis Colon Rectum, 45, 776, 10.1007/s10350-004-6297-7

2005, Clinical approach to diseases of ileal pouch-anal anastomosis, Am J Gastroenterol, 100, 2796, 10.1111/j.1572-0241.2005.00278.x

2000, Pharmacotherapy for inducing and maintaining remission in pouchitis, Cochrane Database Syst Rev, CD001176

1994, Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis, Dig Dis Sci, 39, 1193, 10.1007/BF02093783

2010, Treatment and prevention of pouchitis after ileal-pouch anal anastomosis for ulcerative colitis, Cochrane Database Syst Rev, 6, CD001176

2007, Oral budesonide in the treatment of chronic refractory pouchitis, Aliment Pharmacol Ther, 25, 1231, 10.1111/j.1365-2036.2007.03306.x

2007, Combined ciprofloxacin and tinidazole therapy in the treatment of chronic refractory pouchitis, Dis Colon Rectum, 50, 498, 10.1007/s10350-006-0828-3

1999, Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis, Aliment Pharmacol Ther, 13, 713, 10.1046/j.1365-2036.1999.00553.x

2005, Rifaximin-ciprofloxacin combination therapy is effective in chronic active refractory pouchitis, Colorectal Dis, 7, 182, 10.1111/j.1463-1318.2004.00746.x

2002, Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis, Aliment Pharmacol Ther, 16, 909, 10.1046/j.1365-2036.2002.01203.x

2012, Impact of budesonide on liver function tests and gut inflammation in patients with primary sclerosing cholangitis and ileal pouch anal anastomosis, J Crohns Colitis, 6, 536, 10.1016/j.crohns.2011.10.011

2014, Oral beclomethasone dipropionate in chronic refractory pouchitis, J Crohns Colitis, 8, 649, 10.1016/j.crohns.2013.12.001

2002, Budesonide enema in pouchitis–a double-blind, double-dummy, controlled trial, Aliment Pharmacol Ther, 16, 27, 10.1046/j.1365-2036.2002.01139.x

1993, Cyclosporin A retention enemas in refractory distal ulcerative colitis and ‘pouchitis’, Scand J Gastroenterol, 28, 701, 10.3109/00365529309098276

1989, Short-chain fatty acid irrigation in severe pouchitis, N Engl J Med, 321, 1416, 10.1056/NEJM198911163212019

1999, Short-chain fatty acid [SCFA] enema therapy for treatment-resistant pouchitis following ileal pouch-anal anastomosis [IPAA] for ulcerative colitis, Gastroenterology, 106, A784

1993, Chronic pouchitis after ileal pouch-anal anastomosis: responses to butyrate and glutamine suppositories in a pilot study, Mayo Clin Proc, 68, 978, 10.1016/S0025-6196(12)62270-8

2010, Efficacy of infliximab in refractory pouchitis and Crohn’s disease-related complications of the pouch: a Belgian case series, Inflamm Bowel Dis, 16, 243, 10.1002/ibd.21037

2008, Short-term treatment with infliximab in chronic refractory pouchitis and ileitis, Aliment Pharmacol Ther, 27, 759, 10.1111/j.1365-2036.2008.03656.x

2012, Efficacy of infliximab rescue therapy in patients with chronic refractory pouchitis: a multicenter study, Inflamm Bowel Dis, 18, 812, 10.1002/ibd.21821

2012, Efficacy of adalimumab rescue therapy in patients with chronic refractory pouchitis previously treated with infliximab: a case series, Eur J Gastroenterol Hepatol, 24, 756, 10.1097/MEG.0b013e3283525a7b

2004, An enema formulation of alicaforsen, an antisense inhibitor of intercellular adhesion molecule-1, in the treatment of chronic, unremitting pouchitis, Aliment Pharmacol Ther, 19, 281, 10.1111/j.1365-2036.2004.01863.x

2013, Topical tacrolimus therapy for antibiotic-refractory pouchitis, Dis Colon Rectum, 56, 1166, 10.1097/DCR.0b013e31829ebd83

2000, Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial, Gastroenterology, 119, 305, 10.1053/gast.2000.9370

2004, Once daily high dose probiotic therapy [VSL#3] for maintaining remission in recurrent or refractory pouchitis, Gut, 53, 108, 10.1136/gut.53.1.108

2015, Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis, Cochrane Database Syst Rev, Cd001176

2003, Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial, Gastroenterology, 124, 1202, 10.1016/S0016-5085(03)00171-9